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Abstract 
Fortified blended foods (FBFs), in particular, corn-soybean blend (CSB), are food aid 
commodities widely used in infant and young children supplementary feeding programs. A 
United States Agency for International Development (USAID) Food Aid Quality Review report 
recommended developing novel FBFs using local alternative commodities such as sorghum and 
improving the nutritional quality of FBFs using extrusion processing.  
Extruded sorghum-cowpea, sorghum-soy and corn-soy FBFs were developed and 
compared with the non-extruded FBFs corn-soy blend 13 (CSB13) and corn-soy blend plus 
(CSB+) using the in-vitro digestion/Caco-2 cell model. Dry FBFs’ iron and vitamin A content 
ranged from 8.0 to 31.8 mg/100g and 0.54 to 1.67 mg/100g, respectively. Following in-vitro 
digestion, bioavailable iron and vitamin A levels were determined by measuring Caco-2 cell 
ferritin and vitamin A levels in response to 12-hour and 4-hour treatments, respectively, with 
aqueous fractions collected from digested FBFs. Most extruded FBFs’ aqueous fraction iron 
levels were 2- to 7-fold higher (p<0.05) than CSB13 and CSB+. However, Caco-2 cell ferritin 
and vitamin A levels were not significantly different among FBFs. These results suggest that 
consumption of newly developed extruded sorghum-cowpea, sorghum-soy and corn-soy FBFs 
will result in bioavailable iron and vitamin A levels comparable to traditional non-extruded 
CSB13 and CSB+. Thus, extruded sorghum-cowpea FBF may be a suitable alternative to corn-
soybean based FBFs. 
Saw palmetto supplements are one of the most commonly consumed products by men 
with prostate cancer and/or benign prostatic hyperplasia (BPH). Some studies have found 
significant improvements in BPH with saw palmetto supplementation, whereas others found no 
benefits. The variation in the efficacy in these trials may be a result of differences in the putative 
  
active components, fatty acids and phytosterols, of the saw palmetto supplements. We quantified 
fatty acids and phytosterols in 20 commercially available liquid, powder, dried berry, and 
tincture saw palmetto supplements. Liquid saw palmetto supplements contained significantly 
higher (p<0.05) concentrations of total fatty acids (908.5 mg/g), individual fatty acids, total 
phytosterols (2.04 mg/g), and individual phytosterols, than the other supplement categories. Our 
findings suggest that liquid saw palmetto supplements may be the best choice for individuals 
who want to take a saw palmetto supplement.  
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digestion, bioavailable iron and vitamin A levels were determined by measuring Caco-2 cell 
ferritin and vitamin A levels in response to 12-hour and 4-hour treatments, respectively, with 
aqueous fractions collected from digested FBFs. Most extruded FBFs’ aqueous fraction iron 
levels were 2- to 7-fold higher (p<0.05) than CSB13 and CSB+. However, Caco-2 cell ferritin 
and vitamin A levels were not significantly different among FBFs. These results suggest that 
consumption of newly developed extruded sorghum-cowpea, sorghum-soy and corn-soy FBFs 
will result in bioavailable iron and vitamin A levels comparable to traditional non-extruded 
CSB13 and CSB+. Thus, extruded sorghum-cowpea FBF may be a suitable alternative to corn-
soybean based FBFs. 
Saw palmetto supplements are one of the most commonly consumed products by men 
with prostate cancer and/or benign prostatic hyperplasia (BPH). Some studies have found 
significant improvements in BPH with saw palmetto supplementation, whereas others found no 
benefits. The variation in the efficacy in these trials may be a result of differences in the putative 
  
active components, fatty acids and phytosterols, of the saw palmetto supplements. We quantified 
fatty acids and phytosterols in 20 commercially available liquid, powder, dried berry, and 
tincture saw palmetto supplements. Liquid saw palmetto supplements contained significantly 
higher (p<0.05) concentrations of total fatty acids (908.5 mg/g), individual fatty acids, total 
phytosterols (2.04 mg/g), and individual phytosterols, than the other supplement categories. Our 
findings suggest that liquid saw palmetto supplements may be the best choice for individuals 
who want to take a saw palmetto supplement.  
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Preface 
The dissertation includes two studies conducted to determine the bioavailable iron and 
vitamin A in extruded fortified blended foods (FBFs) and the third study that determined the 
fatty acid and phytosterol profiles of commercial saw palmetto herbal supplements. The 
organization of the dissertation is described below.  
Chapter 1 provides information on FBF history, development and nutritional 
improvements. Data on global prevalence of iron and vitamin A deficiency is included. This 
chapter also provides information on methodological differences in the in-vitro digestion/Caco-2 
cell mode literature, iron and vitamin A bioavailability, sorghum and cowpea production, 
antinutritional factors (ANF) and processing methods that reduce ANF. 
Chapter 2 describes a study on bioavailable iron in newly developed extruded sorghum-
cowpea, sorghum-soy and corn-soy FBFs. Here we compared the new FBFs with the traditional 
food aid FBFs; corn-soy blend 13 (CSB13) and corn-soy blend plus (CSB+). This study was 
limited by the fact that the FBFs were low in vitamins A, D, and E. As a result, chapter 2 results 
are considered preliminary.  
Hence, we conducted another study on the new FBFs that contained the recommend 
levels of the vitamins that is described in chapter 3. Chapter 3 assessed both bioavailable iron 
and vitamin A in extruded sorghum-cowpea, sorghum-soy and corn-soy FBFs compared to the 
traditional FBFs; CSB13 and CSB+. Here we modified the methods by using cell lysis buffer for 
harvesting the Caco-2 cells, and by adding FeSO4 positive controls in addition to basal salt 
solution negative control. 
Chapter 4 describes a study on characterizing the fatty acid and phytosterol profiles of 
different commercially available saw palmetto herbal supplements. This study was conducted 
xvii 
first, before changing the focus of my dissertation. It was published in Nutrients in 2013 and has 
been cited multiple times. 
Chapter 5 provides conclusions and future directions about iron and vitamin A 
bioavailability in FBFs and therapeutic effects of bioactive components of saw palmetto 
supplements.
1 
Chapter 1 - Literature Review 
 Introduction 
Globally, more than 2 billion individuals are at risk for multiple micronutrient 
deficiencies [1]. Africa and South-East Asia are highly affected regions with the greatest number 
of individuals with iron deficiency anemia (IDA) and vitamin A deficiency (VDA) [2, 3], the 
two major micronutrient deficiencies of tremendous public health significance.  
This chapter will review the global prevalence of iron deficiency, vitamin A deficiency, 
fortified blended foods, United States Agency for International Development (USAID)-Food Aid 
Quality Review (FAQR) recommendations, antinutritional factors (ANF) in sorghum and 
cowpea, effect of extrusion on ANF and iron bioavailability, iron and vitamin A bioavailability 
using in-vitro digestion/Caco-2 cell model and methodological differences in in-vitro 
digestion/Caco-2 cell model. 
 
 Global prevalence of iron deficiency  
 Iron deficiency is one of the major micronutrient deficiencies in the world along with 
vitamin A, zinc and iodine deficiencies. Iron deficiency is primarily caused by diets low in iron, 
deficient in animal protein, and predominantly based on cereals and legumes that are low in iron 
and /or contain iron inhibitors [4, 5]. Increased iron demands during growth, pregnancy, 
lactation, malabsorption syndrome, malaria, genetic disorders, and blood loss due to intestinal 
parasites are some other causes for iron deficiency [5]. Iron deficiency anemia affects the 
physical growth and cognitive performance in children, immunity, physical capacity and work 
performance in all age groups. It also increases the risk of maternal and infant mortality [6, 7]. 
2 
 Iron deficiency prevalence data is limited due to difficulty in its assessment. A 
combination of measurements such as, serum ferritin, serum transferrin receptor, transferrin 
saturation are used as indicators of iron status. As it is often not feasible to assess multiple 
indicators of iron status at population level the data on global iron deficiency is not available. 
Hence, anemia prevalence estimates assessed by blood hemoglobin concentration are used as a 
measure of IDA [6].  According to World Health Organization (WHO), blood hemoglobin 
concentration of < 11 g/dL for pre-school children and pregnant women, and < 12 g/dL for non-
pregnant women are anemia thresholds. Anemia prevalence is highest among pre-school children 
(47%), pregnant women (42%), and non-pregnant women (30%, Table 1-1) [2]. Africa has the 
highest proportion of anemia, where more than half of pre-school children and pregnant women 
are anemic (Table 1-1). However, South-East Asia has the largest population of 315 million 
anemic individuals. With the exception of two to three countries, all of the WHO member 
countries have mild to severe public health significance for anemia in vulnerable groups. 
Globally, anemia is of severe public health significance in at least 68 countries [2]. 
Table 1-1 Anemia prevalence and number of individuals affected in pre-school-age children, 
pregnant women and non-pregnant women in each WHO region 
WHO region Pre-school-age children Pregnant women Non-pregnant women 
  
Prevalence  
(%) 
# affected 
(millions) 
Prevalence 
(%) 
# affected 
(millions) 
Prevalence 
(%) 
# affected 
(millions) 
Africa 67.6  83.5  57.1  17.2  47.5  69.9  
Americas 29.3  23.1  24.1  3.9  17.8  39  
South-East Asia 65.5  115.3  48.2  18.1  45.7  182  
Europe 21.7  11.1  25.1  2.6  19  40.8  
Eastern Mediterranean 46.7  0.8  44.2  7.1  32.4  39.8  
Western Pacific 23.1  27.4  30.7  7.6  21.5  97  
Global 47.4  293.1  41.8  56.4  30.2  468.4  
Source: Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia [2].  
WHO estimates anemia prevalence in non-industrialized countries to be, 52% of pregnant 
women, 48% of children aged 5-14 years, 42% of all women and 39% of children under 5 years 
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[6]. Whereas, in industrialized countries 23% of pregnant women, 5.9% of children aged 5-14 
years, 10% of all women and 20% of children under 5 years are anemic. It is notable that percent 
pregnant women with anemia in non-industrialized countries is 2-times higher than the 
prevalence in industrialized countries [6]. 
 
 Global prevalence of vitamin A deficiency  
Vitamin A is an essential micronutrient needed in smaller amounts for normal vision, 
immunity and reproductive functions. Vitamin A deficiency (VAD) is generally associated with 
low dietary intakes of preformed vitamin A [8]. Infants, young children and pregnant women are 
at greater risk of vitamin A deficiency disorder xerophthalmia, a condition characterized by dry 
conjunctiva and cornea. Vitamin A deficiency is assessed by clinical examination for night 
blindness and biochemical examination for low serum or plasma retinol [3]. 
Current VAD estimates are based on 1995-2005 WHO data available in the Vitamin and 
Mineral Nutrition Information System (VMNIS) [3]. WHO criteria for VAD include history of 
night blindness and serum/plasma retinol cut-off of < 0.70 µmol/l. A prevalence of ≥ 5% night 
blindness in pre-school children below 5 years, and ≥ 20% low serum/plasma retinol (< 0.70 
µmol/l) in pregnant women is considered a severe public health problem. 
Worldwide, night blindness has been estimated to affect 5.2 million pre-school children 
and 9.8 million pregnant women corresponding to 0.9% and 7.8% of the population at risk of 
VAD (Table-1-2). Similarly, low serum retinol concentration, also referred to as biochemical 
VAD, has been estimated to affect 190 million pre-school children and 19.1 million pregnant 
women corresponding to 33% and 15% of the population at risk of VAD, globally (Table 1-2). 
4 
Africa and South-East Asia are the most affected regions with highest number of pre-
school children and pregnant women with VAD. Compared to number of individuals affected 
globally, Africa has around ½ of the pre-school children with night blindness and South-East 
Asia has around ½ of the pre-school children with low serum retinol and around 1/3rd of pregnant 
women with both night blindness and low serum retinol (Tables 1-2, 1-3).   
Table 1-2 Prevalence of night blindness in WHO regions (1995-2005). 
WHO region Pre-school-age children Pregnant women 
  
Prevalence 
(%)  
Number affected 
(millions) 
Prevalence 
(%) 
Number affected 
(millions) 
Africa 2.0  2.55  9.8  3.02  
Americas 0.6  0.36  4.4  0.50  
South-East Asia 0.5  1.01  9.9  3.84  
Europe 0.8  0.24  3.5  0.22  
Eastern Mediterranean 1.2  0.77  7.2  1.09  
Western Pacific 0.2  0.26  4.8  1.09  
Global 0.9  5.17  7.8  9.75  
Source: WHO. Global prevalence of vitamin A deficiency in populations at risk 1995–
2005. WHO Global Database on Vitamin A Deficiency, Geneva, World Health Organization, 
2009 [3]. 
 
Table 1-3 Prevalence of low serum retinol (< 0.70 µmol/l) in WHO regions (1995-2005). 
WHO region Pre-school-age children Pregnant women 
  
Prevalence 
(%) 
Number affected 
(millions) 
Prevalence 
(%) 
Number affected 
(millions) 
Africa 44.4  56.4  13.5  4.18  
Americas 15.6  8.68  2.0  0.23  
South-East Asia 49.9  91.5  17.3  6.69  
Europe 19.7  5.81  11.6  0.72  
Eastern Mediterranean 20.4  13.2  16.1 2.42  
Western Pacific 12.9  14.3  21.5  4.9  
Global 33.3  190  15.3  19.1  
Source: WHO. Global prevalence of vitamin A deficiency in populations at risk 1995–
2005. WHO Global Database on Vitamin A Deficiency. Geneva, World Health Organization, 
2009 [3]. 
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 International food aid 
The International Food Aid Information System (INTERFAIS), developed by World 
Food Programme (WFP) provides information on global food aid deliveries. According to 
INTERFAIS database, the total global food aid in 2012 was 5 million metric tons, of which 58% 
was donated by WFP (Table 1-4).  The major recipient of food aid is Sub-Saharan Africa (63%), 
followed by Asia (22%) [9].  
Table 1-4 Global food aid flows to different WHO regions (2008-2012). 
 2008 2009 2010 2011 2012 
 Food aid deliveries (million mt) 
Global food aid deliveries  6.5 6.3 6.9 5 5 
WFP share of total  4 4 4.3 3.3 2.9 
 Global food aid deliveries (%) 
Sub-Saharan Africa 63 64 60 62 63 
Asia  24 23 27 21 22 
Eastern Europe and CIS  2 2 1 0 0 
Latin America and the Caribbean  5 5 8 7 4 
Middle East and North Africa 6 6 4 10 11 
CIS -Commonwealth of Independent States  
 
 Fortified blended foods 
FBFs are food aid commodities distributed under Title II of Public Law 480 (P.L. 480) of 
the Food For Peace (FFP) program. FBFs, introduced in 1966, were donated by US government 
to combat hunger and malnutrition in food insecure countries. Initially, FBFs were developed as 
food aid commodities to improve child nutrition. Later, they were modified to supplement 
moderately malnourished children by adding sugar and vegetable oil. In the subsequent years, 
FBFs were upgraded to adjust the macronutrient and micronutrient composition and were 
supplemented to other primary beneficiary groups such as pregnant women, lactating women, 
6 
and individuals affected with human immunodeficiency virus (HIV) and tuberculosis (Table 1-5) 
[10].  
Table 1-5 Primary beneficiary groups. 
 Prevention of stunting (linear growth promotion) among children 6–24 months 
 Management of moderate wasting among children 6–59 months 
 Meeting the elevated protein and micronutrient needs of nutritionally-vulnerable 
pregnant and lactating women 
 Management or prevention of moderate wasting among people (including adults) 
living with HIV or AIDS 
Source: Webb et al (2011) [14]. 
 Later, FBFs were used to supplement the overall diet of food insecure populations. They 
are commonly distributed in maternal and child health nutrition (MCHN) programs and school-
meal programs. FBFs are also provided during emergency situations such as natural disasters and 
in refugee camps since the local food resources are severely limited [11]. 
FBFs are value-added foods composed of cereal and legume flour with added vegetable 
oil and vitamin-mineral mix. The grains and legumes are partially precooked to denature ANF, 
increase digestibility, palatability and decrease cooking time [12]. The major cereals that are 
used are corn and wheat, while soybean is the major legume. FBFs generally contain 75-80% 
cereals, 20-25% legumes and a micronutrient premix (Table 1-5) [13]. 
 The initial FBF formulations; corn soy milk (CSM) and wheat soy milk (WSM) were 
developed in 1966. They were high in protein 17.9 mg/100g and low in fat 6.3 mg/100g 
compared to the current FBF CSB13 that contains 15.9 mg/100g protein and 8.7 mg/100g fat 
[12, 14]. US agricultural surpluses affect the quantity and composition of FBF formula. Because 
of the deficit in US milk supply during 1989, dried skim milk powder was removed from CSM 
and WSM and instead CSB and wheat soy blend (WSB) developed without dried skim milk 
powder. FBFs have been upgraded several times to meet the macronutrient and micronutrient 
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requirements of the target groups. For instance, in 1988 vitamin A levels were doubled and in 
1998, magnesium was added and zinc levels were increased [15].  
The main donors of CSB are the USAID, WFP and United Nations Children's Fund 
(UNICEF). Because these organizations have different product specifications, CSB differs in 
nutritional content from one source to another (Table 1-6). USAID CSB commodity 
requirements are regulated by the United States Department of Agriculture (USDA), whereas 
local variants of CSB are regulated by WFP and UNICEF [11, 13].  
Table 1-6 Ingredient and macronutrient composition of CSB from three donor agencies. 
Ingredient WFP 
% by weight 
UNICEF 
 % by weight 
USAID 
% by weight 
Corn Whole maize (white 
or yellow): 75-80 
Whole maize:  
70–80 
Cornmeal, extruded (dehulled, 
degermed): 69.55 
Soy Whole soy beans: 
20–25 
Whole soy beans: 
20–30 
Soy flour (dehulled, defatted): 
21.85 
Vegetable oil – – Soybean oil: 5.5 
Sugar – 5–10 – 
Energy, kcal (minimum) 380 400 377 
Protein % (minimum) 14 14 16.7 
Fat % (minimum) 6 6 6 
Crude fiber % (max) 5 5 2 
Source: Fleige et al, 2010 [11]  CSB, corn soy blend; UNICEF, United Nations Children’s Fund; 
USAID, US Agency for International Development; WFP, World Food Programme. 
 
CSB distributed by WFP and UNICEF uses whole corn and whole soy. Whereas the 
corn-soy blend distributed by USAID has corn meal derived from dehulled, degermed corn and 
soy flour made from dehulled soy. USAID has introduced a new FBF, CSB+, with heat 
processed corn and soy and improved micronutrient formulation [16]. WFP has another FBF, 
CSB++ that contains additional ingredients such as skim milk powder, sugar and oil [13]. 
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 USAID-Food Aid Quality Review (FAQR) recommendations for FBF improvements 
Resource constraints, reduced global food aid delivery and concerns on whether food aid 
products are meeting the needs of target groups led to a review of Title II food aid products. A 
USAID-FAQR committee reviewed the existing food aid products and made recommendations 
for their improvement. The FAQR includes 35 recommendations to improve USAID food aid 
products and programs. Recommendations related to the nutritional enhancement of FBFs were 
enhancing the macronutrient and micronutrient content, decreasing anti-nutritional factors that 
impair nutrient absorption using processing methods such as extrusion, including animal source 
protein, and developing novel FBFs using local alternative commodities such as sorghum. 
The FAQR recommends sorghum as an alternative cereal because of its low-cost and 
acceptability in Africa. A sorghum–soy or sorghum–pea or other pulse blends, millet–soy, rice–
soy, or other cereal, potato–soy (or other pulse) blends were suggested as alternative FBFs to 
CSB or WSB [14]. 
 
 Sorghum 
Sorghum (Sorghum bicolor) is an ancient crop and a fifth most consumed grain in the 
world after rice, wheat, corn and barley. It is a drought-resistant crop, hence it serves as a major 
food source in semi-arid regions of the world [17]. Sorghum is used in different African food 
preparations such as ogi (fermented weaning food) in Nigeria, injera (fermented pancake-like 
bread) in Ethiopia, nasha (infant porridge) and kisra (traditional bread) in Sudan, mahewu 
(fermented beverage) in Zimbabwe [18] and gowé (malted and fermented beverage) in Benin 
[19]. 
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The total world sorghum production in 2013 was about 62 million metric tons (Figure 1-
1). Thirty one million metric tons were used for food, alcohol, and industrial use. The United 
States ranks 1st and contributed around 17% of the world sorghum production. The other major 
producers of sorghum are Nigeria and Mexico. While majority of the countries consumed 100% 
of their produced sorghum, The US consumes around 54% of its production and exports the 
remaining grain to other countries. The US, sorghum is mainly used for animal feed and ethanol 
production [20, 21]. 
 
 Cowpea 
 Cowpea (Vigna unguiculata), also called black-eyed pea, is a native crop of West Africa. 
Approximately 95% of world cowpea is cultivated in Africa. Cowpea is a drought-tolerant crop 
that adapts well even in the drier regions of tropics. Six million metric tons of cowpea were 
produced in 2013 (Figure 1-2). Nigeria and Niger are the two largest cowpea producers from the 
last 14 years. Together these two countries produce around 4 million metric tons while rest of the 
developing countries producing < 0.6 million metric tons [20, 22]. 
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Figure 1-1 Sorghum production by country, tons, 2013. 
 
 
Source: FAOSTAT, 2013 [20] 
 
 
 
Figure 1-2 Cowpea production by country, tons, 2013. 
 
 
Source: FAOSTAT, 2013 [20] 
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 Antinutritional factors in sorghum and cowpea 
Iron bioavailability has been shown to be poor form cereal and legume based diets [23]. 
Antinutritional factors such as phytates and tannins present in plant based diets form insoluble 
complexes with iron and reduce its bioavailability. ANFs also bind to proteins and reduce their 
digestibility and overall protein quality [24]. Food processing methods like soaking, germination, 
fermentation, cooking [25], dehulling [26], enzymatic treatments [27], chemicals [28], and 
extrusion [18] have been shown to decrease the ANF concentrations and improve iron 
bioavailability from cereals and legumes.  
 Phytates  
Phytic acid or phytate (myoinositol hexakisphosphate, IP6) is widely present in cereals, 
legumes and oil seeds [29, 30]. Phytate is the major source of storage phosphorus for plants. 
During germination phytate is degraded, and released phosphorus is utilized for the plant growth. 
Phytate is mostly present in the aleurone layer in cereals and in cotyledons in legumes. Corn is 
different from other cereals as most of its phytate is present in germ [29].  
Phytate content in a grain variety is influenced by its growing environment and genotype 
[31]. Phytate content in African sorghum cultivars varies greatly. When 76 locally grown 
sorghum varieties were analyzed, their phytate content ranged from 4.5 to 35.5 g/kg [31]. In 
another study, phytate content in white sorghum cultivars range from 5.6 to 6.0 g/kg [32]. 
Compared to other legumes, cowpea showed significantly lower levels of phytate (4.6 g/kg) 
compared to lima beans (9.0 g/kg), African yam bean (7.0 g/kg) and pigeon pea (6.0 g/kg). 
However, cowpea cultivars from India seem to have higher phytate content, the phytate content 
in four brown cowpea varieties ranged from 8 to 9 g/kg [33]. 
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 Tannins 
 Tannin is a naturally occurring polyphenol and a major ANF along with the phytate in 
cereal and legume based diets [34]. Tannins are mostly present in the seed coats, thus, colored 
varieties indicate a tannin concentration [26].  Tannin forms insoluble chelates with iron and 
inhibits its absorption. Tannin content of grains is also influenced by the soil where they grow 
[35]. When 198 Indian sorghum varieties were analyzed, the tannin content ranged from 10-2056 
mg/100g. However, half of the analyzed samples had tannin values < 65 mg/100g and only 5% 
had values > 400 mg/100g. Indian native varieties tended to have more tannin than the hybrid 
and high-yielding varieties [35].  
Tannin content of cowpea also varied between cultivars. Four different varieties of 
cowpea- blackeye, light brown, mottled brown and maroon-red cultivars had tannins ranging 
from 0.3-6.9 mg catechin equivalents/g. However, another variety of cowpea widely used in 
Egypt had higher tannin concentration of 210 mg/100g [36]. 
 Preparation methods that reduce antinutritional factors  
 Household food preparation methods such as soaking, germination, fermentation and 
pressure cooking have been shown to decrease phytates [36]. As phytate is water soluble, 
soaking the grains for extended period of time leaches of this ANF. The beneficial effects of 
these processing methods have been related to activation of native and bacterial phytase enzyme 
[25].  
 When sorghum samples were soaked for 20 hours, phytate content was reduced by 32%. 
Also, germination of sorghum for 72 hours caused a similar 35% decrease in phytate content 
[32]. Duration of soaking and germination had an effect on extent of phytate reduction. In a 
sorghum-based infant porridge, phytate content decreased with increased soaking and 
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germination time. The phytate lowering effect was further enhanced when germination was 
combined with fermentation [38].  In a cowpea sample, germination for one week caused a 
significant 5-fold increase in native phytase enzyme activity and a 5-fold decrease in phytate 
content [37].  
 Other methods such as acid-salt washing with ultracentrifugation and phytase enzyme 
treatments have also been shown to be effective in reducing the phytate content to negligible 
amounts. When soy protein isolate was treated with continuous acid-salt washing, phytate 
content reduced from 8.4 to 0.2 mg/g (98%), and furthermore, a decrease from 6.5 to < 0.01 
mg/g (99.8%) was observed with phytase treatment [28]. 
 Mechanical processing such as decortication in cereals [18] and dehulling in legumes 
[26] has been shown to reduce the tannin content. As tannins are highly localized in the outer 
layers of grains [26], mechanical removal of pericarp and seed coats lowers tannin 
concentrations. In three Zimbabwean tannin-sorghum varieties, decortication decreased tannin 
levels 79 to 92% [18]. Dehulling legumes, such as cowpea, also reduced tannin content by 98% 
[26].  Other methods such as boiling and pressure cooking also caused 2-3 times significant 
reduction in the tannin content [39].  
Similar to the effects on phytate, germination and fermentation reduce tannin content in 
cereals and legumes. Tannin content decreased from 429.5 to 174.1 mg/100 g dry matter during 
sorghum germination [19]. More tannin reduction was observed when germination was 
combined with cooking. When cowpea seeds were cooked by either ordinary or pressure 
cooking, tannin content reduced by approximately 40%, whereas, more than 60% reduction was 
observed when germinated cowpea was cooked [36]. 
14 
Most of the traditional preparation methods activate native and bacterial phytase enzyme 
and give modest decreases in phytate content. However, complete removal of phytate is 
recommended to achieve higher iron bioavailability. Even though it is not possible with the 
existing phytate removal methods, a commercial phytase enzyme can degrade phytate 
completely. When phytase was added to aquatic slurry of cereals, maintained at optimum pH and 
temperature, it can completely degrade phytate in approximately 1-2 hours. However, the cost of 
1-2 dollar cents per kg food to be dephytinized and safety regulations limit this enzyme usage. 
As commercial phytase is produced from Aspergillus Niger, which is a genetically modified 
organism (GMO), its usage differs among countries depending on their safety regulations [27]. 
In addition to this, phytase has GRAS (Generally Regarded As Safe) status only for individuals 
aged 3 years and above [13]. De Pee & Bloem (2009) recommends exploring phytase treatment 
options to improve the mineral bioavailability from FBFs by adding it during production such 
that the heat processing destroys the enzyme and final product that reaches the consumers will be 
free of phytase [13]. 
Effect of antinutritional factors on iron bioavailability 
 It is unlikely that phytate will be decreased to < 10% or completely removed to achieve 
maximum iron absorption with traditional methods such as soaking, germination, and 
fermentation. Two approaches that have achieved this affect include acid-salt washing, and 
phytase enzyme treatments, which were shown to reduce phytate content by 98% and 99.8%, 
respectively. While the difference in phytate content between the two treatments is slight, their 
effect on iron bioavailability is great. Acid-salt washing increased iron bioavailability by 2-fold, 
whereas phytase treatment increased the bioavailability by 5-fold [28]. 
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Iron bioavailability was most influenced by phytate-to-iron molar ratio (Phyt/Fe molar 
ratio) rather than phytate content. Iron bioavailability was impaired at Phyt/Fe molar ratio of 
greater than 14 [31]. Better iron absorption was observed with Phyt/Fe molar ratio 1:1, and the 
absorption was much better with 0.4:1 [27]. Iron bioavailability was similar when iron fortified 
white cowpea meal with low polyphenol (PP) (74 mg/serving), and red cowpea meal with high 
PP (158 mg/serving) were administered to young women. Both cowpea varieties contained 
similar Phyt/Fe molar ratio. It seems that iron bioavailability of cowpea is mostly influenced by 
Phyt/Fe molar ratio rather than polyphenol content [40]. 
 
 Extrusion 
Extrusion is a high-temperature process that cooks food under high pressure in 
combination with moisture and mechanical shear [41]. During this heat treatment, phytates may 
be degraded to lower forms of inositol phosphates with lower than 5 phosphates. Extrusion 
technology has been shown to decrease the ANF in legumes [25] and oil seeds [42]. The 
desirable effects of this cost-effective method include increased starch and protein digestibility, 
increased palatability, decreased viscosity, and decreased ANF that results in improved iron 
bioavailability [25, 43-45]. 
Lipid levels in the food effect the extrusion process and final product texture. During 
extrusion starch and proteins present in the food act as structure forming biopolymers that 
provide necessary viscosity and elasticity for good expansion of the extrudate. Whereas, lipid 
ingredients or added oils provide lubrication to the flour particles and smooth flow of extrudate. 
However, lipid levels above a critical point, such as more than 5%, decreases the expansion ratio 
[46]. Hence, extrusion of high fat foods is not advisable, as they interfere with extruder 
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performance. As defatting improves extrusion process, degermed corn and defatted soy are 
commonly used in extruded food products [41, 47]. 
In addition to the starch, protein and lipid levels in the feed, extruder barrel temperature, 
screw speed and feed moisture affect the expansion ratio and bulk density of the extrudate. A 
higher expansion ratio, an indicator of puffiness; and a lower bulk density, an indicator of 
porosity, are desirable physicochemical and sensory characteristics in the final product [48]. 
Also, mild extrusion conditions such as low barrel temperature and high feed moisture favor 
nutrient retention and decrease lipid oxidation, whereas severe extrusion conditions such as, high 
temperature (≥ 200º C) and low moisture (≤ 15%) can cause nutrient destruction [49]. 
 Effect of extrusion on antinutritional factors and iron bioavailability 
El-Hady & Habiba (2003), studied the effect of extrusion conditions such as barrel 
temperature and feed moisture in reducing ANF from soaked legumes [25]. Faba beans, pea 
seeds, chickpeas and kidney beans were soaked for 16 hours, extruded and analyzed for ANF. 
Both soaking and extrusion significantly reduced phytate and tannin levels. The higher barrel 
temperature and higher feed moisture content of 180º C and 22% were more effective in 
decreasing phytate and tannin levels than lower temperature and moisture content of 140º C and 
18% [25]. A maximum tannin reduction of 99% in sorghum [18] and 97% in peas and kidney 
beans [44] were observed with extrusion.   
Extrusion processing has shown increased iron availability and protein digestibility 
compared to roasting [50]. Extruded and roasted African infant formulas composed of pearl 
millet (65%), peanut (15%) and cowpea (10%) with and without skim milk powder (4%) were 
subjected to in-vitro digestion and dialysates were analyzed. Extruded infant formulas showed 
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3.5-6.5 times higher iron availability and 10% improved protein digestibility compared to roasted 
formulas.  
The effect of extrusion on chickpea iron bioavailability was assessed by the hemoglobin 
regeneration method in anemic rats and compared with home-cooking [48]. Both the methods 
caused improvements in iron bioavailability compared to control diets containing ferrous sulfate, 
with no significant difference between extrusion-cooked and home-cooked chickpea groups. The 
total phytate and total tannin content were not different between home-cooked and extrusion-
cooked chickpeas, but IP5 levels were significantly decreased in extrusion-cooked chickpeas. 
Considering the observations that both IP6 and IP5 inhibit iron absorption [51], a decrease in IP5 
fraction of phytate in extruded chickpea could have caused proportional increase in iron 
absorption compared to home-cooked. However, the small amount of phytate in chickpeas 
compared to other legumes may be the reason for not causing detectable improvements in iron 
absorption. Also, extrusion conditions such as 14% feed moisture and 130ºC barrel temperature 
may not be sufficient to cause a profound destruction in ANF [48].   
Alonso et al (2001), studied the effect of extrusion on mineral bioavailability in pea seed 
and kidney bean seed meals fed to male rats. A significant increase in iron bioavailability was 
observed in extruded seed meals. Also, a significant reduction in total phytate (4-21%) and total 
tannin (70-92%) content was observed in extruded seed meal. Most importantly, extrusion 
cooking caused a significant decrease and partial hydrolysis of inositol hexaphosphate (IP6) to 
low-molecular weight phytates such as penta (IP5) and tetraphosphates (IP4) [44]. This shift 
towards lower phytate fractions in synergy with a maximum of 92% tannin reduction, may have 
caused increased iron bioavailability.   
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 Iron fortificants 
Some iron compounds are highly bioavailable, but associated with drawbacks such as 
development of off colors and flavors in the fortified food. Iron fortification is not effective if the 
food vehicle contains iron inhibitors. Under these circumstances iron salts that do not change the 
organoleptic properties of fortified food, and overcome the inhibitor’s effect, seem to be more 
effective in improving the intake and iron bioavailability [52]. 
Elemental iron is the most commonly used commercial fortificant, and iron salts such as 
ferrous sulfate (FeSO₄) can cause undesirable organoleptic changes in the food during storage. 
However, there is limited information on the bioavailability of elemental iron in humans. Hoppe 
et al (2005), evaluated five commercially available and two developmental elemental iron 
powders in a randomized, double blind, cross-over study in male blood donors [53]. Subjects 
were given wheat rolls fortified with 100 mg FeSO₄ or 100 mg elemental iron powders. The 
relative bioavailability, measured by serum iron area under curve (AUC) values compared to 
FeSO₄, of all the seven elemental powders, ranging from 36-65%, was significantly lower than 
FeSO₄. However, when one of the elemental iron powders was administered along with 50 mg 
ascorbic acid (AA), the relative bioavailability was significantly increased and the absorption 
was similar to FeSO₄. This study indicates the poor bioavailability of elemental iron, hence, co-
fortifying the elemental iron powders with ascorbic acid may enhance the iron bioavailability 
[53].  
Sodium iron EDTA (NaFeEDTA) is a protected iron compound that prevents the 
fortificant iron from reacting with phytate present in the food or diet. NaFeEDTA not only 
provides supplemental iron, it also protects native iron in the diet from phytates and tannins [54]. 
Cowpea meal fortified with NaFeEDTA significantly increased hemoglobin levels, serum 
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ferritin, body iron stores and significantly decreased IDA by 47% in Ghanian school children 
compared with nonfortified flour [55]. This indicates the effectiveness of NaFeEDTA in 
improving iron absorption even in the presence of iron inhibitors inherent to cowpea. Another 
study among adolescent children also found significant increase in iron bioavailability (9%) with 
NaFeEDTA compared to FeSO₄ (5.5%) [56]. 
A recent study found increased (6.4% vs. 4.1%) iron absorption from a millet porridge 
fortified with 1:1 mixture of NaFeEDTA: FeSO₄ compared to FeSO₄ alone in children aged 2 to 
2.5 years [57]. Using NaFeEDTA in combination with other iron compounds may be a good 
strategy for iron fortification of food vehicles, as NaFeEDTA increases the native iron 
bioavailability and the combination with other iron salts keeps the EDTA levels under acceptable 
limits. 
 Vitamin A bioavailability 
The dietary forms of vitamin A are provitamin A carotenoids such as α-carotene, β-
carotene and β-cryptoxanthin found in plant foods, and preformed vitamin A found in animal 
food sources. The vitamin A value of dietary β-carotene and α-carotene and β-cryptoxanthin is 
1/12th and 1/24th , respectively, that of retinol [58]. Insufficient intake of dietary vitamin A and or 
inefficient absorption can lead to vitamin A deficiency. 
The bioavailability of the fat-soluble nutrients may depend on micellarization in the 
intestine and incorporation into chylomicrons in the enterocyte. Dietary fat stimulates pancreatic 
and biliary secretions necessary for lipid digestion and micelle formation. While dietary fat 
improves mixed micelle formation, dietary fiber may interfere with it by partitioning bile salts 
and fat [59]. However, soluble fiber increases vitamin A bioavailability by promoting post-
absorptive conversion of β-carotene to vitamin A in Mongolian gerbils [61].  
20 
 Iron bioavailability 
Iron bioavailability is influenced by several factors such as iron concentration, enhancers 
and inhibitors of iron absorption, interaction with other dietary factors and host-related factors 
such as iron deficiency, iron adequacy, physiological status and disease state [67]. Dietary iron 
exists in two forms, as heme iron in animal foods and as non-heme iron in plant foods. Non-
heme iron exists either as ferric (Fe3+) or ferrous (Fe2+) form. In order to be absorbed into the 
enterocyte iron should be in the ferrous form.  While heme iron is absorbed directly into the 
enterocyte by endocytosis, non-heme iron is absorbed through a non-specific divalent metal 
transporter 1 (DMT1) expressed on the apical side of the enterocyte.  
In vivo iron bioavailability assessed by human balance studies and animal absorption 
studies are expensive and time consuming. Differences between animal and human iron 
metabolism limit the use of animal models for iron bioavailability studies.  Human studies using 
radiolabeled iron provide accurate information on iron bioavailability, however, the risk of 
radiation exposure limits this kind of studies [67].  
 
 In-vitro digestion/Caco-2 cell model 
The parental Caco-2 cells were isolated from the colon adenocarcinoma of a 72 year old 
Caucasian patient during 1970 (ATCC). Even though they are originated from colon, after 
differentiation, usually within 2-weeks post-confluence, Caco-2 cells behave like mature 
enterocytes by developing brush border and expressing the digestive enzymes such as sucrase, 
maltase, lactase and alkaline phosphatase. Similar to enterocytes, differentiated Caco-2 cells 
express iron transporter DMT-1 [75]. Due to the nature of the model, it is important to use fully 
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differentiated Caco-2 cells to study the nutrient uptake as it affects the expression of transporters 
and consequent nutrient uptake by Caco-2 cells [76]. 
In-vitro digestion combined with Caco-2 cell model is an advanced method over other in-
vitro iron availability techniques such as solubility and dialyzability. The solubility method 
involves exposing the food to lower pH conditions, like in stomach, and measuring the soluble 
iron in the digest. In the dialyzability method, simulated gastrointestinal digestion is conducted 
using pepsin, pancreatin and bile extracts. Then the intestinal digest is incubated in the presence 
of a dialysis bag. The amount of iron that moves into the bag is used to estimate iron 
bioavailability. Iron in the dialysate represents low molecular weight soluble iron (< 10,000) that 
can pass through a dialysis membrane [67].   
Observations of no correlation between iron solubility and iron bioavailability lead to 
adding a living component of Caco-2 cells to in-vitro digestion technique to study beyond the 
digestion, i.e. uptake by enterocytes [77]. While in-vitro digestion determines iron availability, 
this technique combined with the Caco-2 cell model allows for measurement of the complete 
digestion and bioavailability of a nutrient.  
In-vitro digestion predominantly consists of two phases. 1) Gastric or pepsin-HCl 
digestion- during which food samples are incubated with pepsin-HCl solution for 2 hours at pH 2 
in a shaking water bath at 37°C. 2) Intestinal digestion- during which aliquots of gastric digests 
are incubated with pancreatin-bile extracts for 2 hours at pH 6 in a shaking water bath at 37°C, 
with a dialysis bag added to the beaker. At the end of the digestion, the dialysis bag is removed 
and the contents collected for analysis [67]. However, Glahn et al (2009), modified this method 
to accommodate the coupling of in-vitro digestion and Caco-2 cell model (Figure 1-3).  In this 
new method, gastric digestion is conducted on a rocking platform shaker kept in an incubator at 
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37°C for 1 hour. Intestinal digestion is carried out in the top compartment of the two-chamber 
system in a 6-well plate with Caco-2 cells in the bottom chamber. Inserts fitted with dialysis 
membrane with 15 K Da molecular weight cut-off are placed in 6-well plates to create a two-
chamber system. Aliquots of gastric digest are added to the top compartment of the 6-well plates 
kept on a rocking platform shaker with digestion continued for 2 hours. This model allows the 
simultaneous intestinal digestion and nutrient uptake by Caco-2 cells, similar to the intestinal 
physiological conditions [78]. Iron bioavailability is measured either by assessing Caco-2 cell 
iron uptake using atomic absorption spectrophotometer (AAS) or by determining caco-2 cell 
ferritin synthesis, an indirect measure of iron bioavailability.     
 
Figure 1-3 In-vitro digestion/Caco-2 cell culture model 
 
 
Source: Glahn et al, 1998 [78] 
 
23 
Earlier iron bioavailability studies using in-vitro digestion/Caco-2 cell model were 
conducted using radiolabeled iron added either intrinsically or externally to the food samples 
[78]. Due to the possible radiation exposure risks, later studies used stable isotopes. In-vitro 
digestion/Caco-2 cell model is, a cost-effective, time saving technique and also an effective 
method to screening foods for better bioavailable varieties [77]. 
In-vitro digestion/Caco-2 cell model has demonstrated similar results compared to human 
iron bioavailability studies [68] such as promoting effects of ascorbic acid [69], inhibitory effects 
of phytates and polyphenols [70] and higher iron bioavailability from animal foods such as beef 
and fish than from corn and green beans [71]. This model has been successfully used in studying 
the effects of seed coat removal [69] on iron bioavailability and for screening different cereal and 
legume genotypes [69, 72]. 
Seed coat removal has been shown to increase iron bioavailability in legumes. Eight 
genotypes of common bean were studied for the effect of seed coat removal and ascorbic acid on 
iron bioavailability [69]. Most bean varieties had poor iron bioavailability of below baseline 
ranging from 1.1-11.5 ng ferritin/mg protein. However, when seed coats were removed iron 
bioavailability increased to 10.8-31.9 ng ferritin/mg protein. Several fold increase was observed 
in ferritin response (68.0-148.0 ng ferritin/mg protein) when ascorbic acid was added to beans 
without their seed coat. Iron bioavailability may have been enhanced because most polyphenols 
are located in seed coats [69]. Another study conducted with 24 varieties of cooked legumes with 
green, red and brown seed coat color found a 2-fold increase in iron bioavailability in dehulled 
lentils compared to whole lentils [73].   
Glahn et al (2002) demonstrated the inhibitory effect of phytic acid and tannic acid on 
iron uptake by Caco-2 cells in the absence of food matrix [70]. An equimolar ratio of 1:1 
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Fe:phytic acid resulted in 70% decrease in iron uptake, and 1:10 ratio of Fe:phytic acid Inhibiting 
iron absorption by 85%. Whereas tannins caused a 92% inhibition in iron uptake even at lowest 
ratio of 1:0.1, indicating that tannins are more potent inhibitors of iron absorption than phytic 
acid. However, other studies observed no correlation between iron bioavailability and phytate 
content [73].  
Ascorbic acid has been shown increasing effect on iron bioavailability in Caco-2 uptake 
studies [69]. The possible explanation for this enhancing effect is that ascorbic acid promotes the 
reduction of ferric iron to ferrous form. Ferrous iron has low affinity to bind and form complexes 
with other molecules such as proteins and also has low tendency to polymerize. Hence, ascorbic 
acid promotes not only the soluble iron but also soluble iron with low-molecular weight that can 
easily be taken up by Caco-2 cells [74]. 
There has been only one study that examined the vitamin A bioavailability in fortified 
foods using in-vitro digestion/Caco-2 cell model [63]. Six different foods; minced pork, beef and 
turkey, apple sauce, bread and mayonnaise were supplemented with vitamin A, cooked and 
subjected to in-vitro digestion/Caco-2 experiment. All three meat samples retained retinol well 
after cooking than the other food samples. Turkey had 4-fold higher retinol in micellar fraction 
than the other meats, which was reflected in the Caco-2 cell uptake. Retinol content in the 
micellar fraction has correlated well (R2 = 0.99) with Caco-2 cell uptake [63].  
 
 Methodological differences in iron bioavailability studies using in-vitro 
digestion/Caco-2 cell model 
The in-vitro digestion/Caco-2 cell model is a widely used and well-accepted method. 
However, differences in digestion technique and culture conditions between laboratories make 
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comparison of results difficult. Due to the lack of standardization of the technique, researchers 
have modified the method according to the experimental design and resources. The major 
methodological differences are described below. A total of 17 studies using the in-vitro 
digestion/Caco-2 model to assess the iron bioavailability in different foods are described under 
this section.  
 Passage number 
While the Caco-2 parental cell line, HTB37, is supplied at a lower passage by ATCC, 
most studies used the cells between passages 20 to 40. However, a few studies used cells with 
high passage number of 53-95 [79, 62].  
 Seeding density 
Most authors seed cells at a density of 5 x 104 cell/cm2 . Higher seeding density promotes 
all the areas of the Caco-2 cell monolayer reaching confluence at the same time [80].     
 Inserts with dialysis membrane 
Iron bioavailability studies, primarily from Glahn’s laboratory, developed a modified in-
vitro digestion/Caco-2 model with dual chamber system. In this method, plastic inserts fitted 
with a 15 K Da molecular weight cut-off dialysis membrane are placed in 6-well plates to create 
two compartments with Caco-2 cells in the bottom one [71]. The second part of the digestion, 
intestinal, was conducted in the top chamber. During this time, soluble or bioaccessible iron 
passes through the dialysis membrane and is taken up by Caco-2 cells in the bottom chamber 
[69, 71]. The dialysis membrane protects the Caco-2 cells from digestive enzymes and bile salts 
added during digestion [81]. This two chamber arrangement, with inserts and dialysis membrane, 
allows for the simultaneous intestinal digestion and uptake, similar to human intestinal digestion. 
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The major limitation of this method is that, ferritin and heme-iron complexes cannot pass 
through the dialysis membrane because their molecular weight is greater than15 K Da [77].   
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Table 1-7  In-vitro digestion/Caco-2 cell method details of different iron bioavailability Studies. 
Refere
nce 
Food sample Passage 
No 
Day 
Caco-2 
cells 
used  
Type of 6-/12-
well plates 
 / T-75-flasks 
Cell 
density 
(cells/cm2) 
Two chambers/  
cells treated 
 directly 
Treatment 
duration 
Aqueous fraction 
(AF) /digesta 
Ferritin 
/cell iron 
method 
[71] Nonradiolabeled 
food  
25-33 13 Collagen treated 50000 Two chamber w/ 
dialysis membrane 
24 hrs 1.5 ml digesta IRA  
[69] Bean genotypes 25-33 13 Collagen treated 50000 Two chamber w/ 
dialysis membrane 
25 hrs 1.5 ml digesta IRA 
[79] Milk- based 
infant formulas 
56-95 14-16 NI 50000 Two chamber w/ 
dialysis membrane 
22 hrs 1 ml dialysate ELISA 
[72] Chinese polished 
rice genotypes 
20-43 21 Collagen coated  50000 Two chamber w/ 
dialysis membrane 
23 hrs 1.5 ml AF  IRA 
[81].  Chinese wheat 
flours 
25 13 Collagen treated 50000 Two chamber w/ 
dialysis membrane 
24 hrs 1.5 ml digesta IRA 
[82] Beverage 
premixes  
NI 14 NI 50000 Two chamber w/ 
dialysis membrane 
24 hrs 2.0 ml digesta ELISA 
[83] Low and high Fe 
bioavailable 
maize lines  
29 13 Collagen treated 50000 Two chamber w/ 
dialysis membrane 
24 hrs 1.5 ml digesta IRA 
[84] Maize 
hemoglobin 
29 15 Collagen treated 
12-well plates 
50000 Cells treated 
directly 
24 hrs  0.5 ml heat 
treated AF 
IRA 
[85] Fortified fruit 
beverages  
30-36 14-16 NI 50000 Cells treated 
directly 
24 hrs  1.0 ml AF ELISA 
[79] Milk based infant 
formulas 
56-95 14-16 NI 50000 Cells treated 
directly 
22 hrs 1.0 ml of 
dialysate 
ELISA 
[73] Lentils 25-33 13 Collagen treated 50000 Two chamber w/ 
dialysis membrane 
24 hrs  1.5 ml digesta IRA 
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[86] Wheat 27-34 13 Collagen treated 47500 Two chamber w/ 
dialysis membrane 
25 hrs  10% of the AF  ELISA 
[60] Fruit beverage 30-40 14-16 NI 50000 Cells treated 
directly 
24 hrs  1.0 ml AF ELISA 
[62] Infant formula 53-55 15-18 T-75 plastic 
flasks 
50000 Cells treated 
directly 
1 hr 18-22.0 ml  AF  AAS  
[64] Micromilled 
wheat 
28 13 NI 50000 Cells treated 
directly 
24 hrs  1.5 ml digesta   ELISA  
[65] Soy root nodules  20-26 15 Collagenized 
12-well plates 
50000 Cells treated 
directly 
24 hrs  0.5 ml AF   IRA 
[66] Complementary 
foods 
46-47 14 Collagen treated 10000 Two chamber w/ 
dialysis membrane 
2 hrs 1.5 ml AF LSC 
AF, aqueous fraction; IRA, immunoradiometric assay; ELISA, enzyme-linked immunosorbent assay; AAS, atomic absorption 
spectrophotometer; LSC, liquid scintillation counter; NI, no information whether the 6-well plates were collagen treated or not. 
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 Incubation duration 
In studies that used aqueous fraction instead of digesta, all the in-vitro digestion phases 
were conducted in a shaking water bath. Aliquots of digesta were centrifuged and collected 
supernatant aqueous fraction, usually 0.5-1.0 ml, was used to treat the Caco-2 cells. The usual 
treatment duration for iron bioavailability experiments was 22-24 hours. However, Latunde-Dad 
et al (2014) and Cilla et al (2007), allowed the food treatments on Caco-2 cells only for 2 hours, 
after that, treatment was replaced with Minimum Essential Medium (MEM) and the incubation 
was continued for additional 22 hours [85, 64]. Higher iron concentration and higher iron 
bioaccessibility of up to > 95% in fruit beverage samples [85], and micromilled wheat flour with 
reduced particle size [64] may be the reasons for choosing the short incubation time in the above 
studies. Another modification of incubation duration is diluting the food treatment after few 
hours of exposure to Caco-2 cells. In a soy root nodule iron bioavailability study, Caco-2 cells 
were treated with 0.5 ml of aqueous fraction for 2 hours then followed by addition of 1 ml 
DMEM and continued incubation for further 22 hours [65]. 
 Dialysis bag 
 In studies that used dialysis bag method [79, 62], gastric digestion was conducted in 
shaking water bath and a dialysis bag was added during intestinal digestion. Dialysate collected 
into the bag at the end of the digestion was used to treat the Caco-2 cells for ferritin synthesis.  
 6-well or 12-well plates/T-75 flasks 
While all the reviewed studies grew cells on 6-well or 12-well plates, Jovani et al (2001) 
cultured cells on T-75 cm2 flasks using the similar cell density of 50000 cells/cm2. However, 
they treated the cells with larger amounts of 18-22 ml of dialysate for a short period of 1 hour 
[62]. 
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 Heat treatment 
Another method heat-treated the digesta before extracting the aqueous fraction that goes 
on to the cells. The major purpose of heat treating the digesta [72, 62, 65], or aqueous fraction 
[84], is to inactivate the proteolytic enzymes that were used during in-vitro digestion that might 
be harmful to the Caco-2 cells during the 24 hour long incubation. Even though the aqueous 
fraction was heat treated, Jovaní et al. (2001) reduced the Caco-2 cell incubation time to 1 hour 
[62].  
 Post-seeding treatment time 
In majority of the studies iron bioavailability experiment was conducted on 13th day post-
seeding. This time was used due to acceptable Transepithelial Electric Resistance (TEER) values 
that indicate Caco-2 cell monolayer integrity, consistency of well protein content [71], and full 
differentiation of Caco-2 cells indicated by maximal sucrase and alkaline phosphatase activity 
[62]. However, experiments have been conducted ranging from 13 to 21 days post-seeding in the 
reviewed studies. As the Caco-2 cell monolayer integrity was lost between 20 and 25 days [62], 
13-20 day post-seeding seems like an optimum time period for the uptake experiment.  
 Biomarkers of iron bioavailability 
Most studies measured Caco-2 cell ferritin, an indirect measure of iron bioavailability by 
using either immunoradiometric assay or enzyme-linked immunosorbent assay (ELISA).  
However, Jovani et al (2001), measured cell iron uptake by AAS [62], and Pynaert et al (2006) 
measured radiolabeled iron uptake by liquid scintillation counter [66] 
The in-vitro digestion/Caco-2 technique with varied cell and culture conditions makes the 
comparison of nutrient bioavailability results difficult. Standardization of this technique using 
31 
reference foods and standard protocols will ensure reproducibility of results and enable inter-
laboratory comparisons.  
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Chapter 2 - Determination of Bioavailable Iron in Sorghum, 
Cowpea, Corn and Soybean Fortified Blended Foods 
 
 Abstract 
Background: Fortified blended foods (FBFs), particularly corn-soybean blend (CSB), 
are food aid products distributed in developing countries. In order to improve FBFs, a United 
States Agency for International Development (USAID) Food Aid Quality Review report 
recommended developing novel FBFs by using local alternative commodities such as sorghum 
and improving the nutritional quality of FBFs by using extrusion processing.  
Objective: The objective of the study was to determine the bioavailable iron levels in 
novel, extruded sorghum-cowpea, sorghum-soy and corn-soy FBFs compared to the traditional 
food aid FBFs; corn-soy blend 13 (CSB13) and corn-soy blend plus (CSB+).  
Methods: Fourteen extruded FBFs; sorghum-cowpea (n=7), sorghum-soy (n=4) and 
corn-soy (n=3), two non-extruded FBFs; CSB13 and CSB+ were prepared as porridges and 
bioavailable iron levels were assessed by measuring Caco-2 cell ferritin (ng ferritin/mg cell 
protein) formation in response to 12-hour treatment with aqueous fractions collected from 
digested FBFs. Control cells were collected at time zero, to measure baseline ferritin content. 
Basal salt solution (BSS) containing no iron was used as a negative control. Dry FBF iron 
concentrations were measured on atomic absorption spectrophotometer (AAS).  
Results: Iron content in extruded dry FBFs ranged from 15.6 to 21.1 mg/100g, while it 
is 8.0 and 31.8 mg/100g in CSB+ and CSB13, respectively. Except two, extruded FBFs 
contained 2- to 4-fold significantly higher (p<0.05) aqueous fraction iron levels than CSB13 and 
CSB+. Following 12-hours of aqueous fraction treatment to Caco-2 cells, there were no 
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significant differences in ferritin levels between newly developed extruded FBFs, traditional 
corn-soy FBFs nor the basal salt solution control.   
Conclusions: Results suggest that consumption of newly developed extruded sorghum-
cowpea, sorghum-soy and corn-soy FBFs will result in bioavailable iron levels comparable to 
traditional non-extruded CSB13 and CSB+ FBFs. Thus, an extruded sorghum-cowpea FBF may 
be a suitable alternative to corn-soybean based FBFs. 
 
 Introduction 
Iron deficiency anemia (IDA) is the major nutritional problem of public health 
significance affecting most of the women and children throughout the world. Iron deficiency 
along with vitamin A, iodine and zinc deficiencies are the four major micronutrient deficiencies 
worldwide [1]. Globally, more than 2 billion people are at risk of these nutritional deficiencies 
[2].   
Fortified blended foods (FBFs) are porridge mixes composed of cereals and legumes that 
have been milled, blended, pre-cooked and fortified with vitamins and minerals. These are the 
major food aid products for young children, women and other vulnerable groups in developing 
countries. Corn soy blend (CSB) is the most widely distributed FBF in a majority of the food aid 
receiving countries [3].  
An United States Agency for International Development (USAID) food aid quality 
review (FAQR) recommended to introduce novel FBFs using cereals that are both culturally and 
nutritionally acceptable in Africa. It recommends sorghum as an alternative to corn or wheat 
because of its low-cost, drought-tolerance and cultural acceptability in Africa (FAQR 
recommendation 18) [4]. Cowpea is a legume that may also be beneficial component of FBFs.  
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Sorghum and cowpea are rich in iron, complement each other by providing the limiting 
amino acids lysine and cysteine missing from the other commodity, which improves protein 
quality [5, 6]. Sorghum and cowpea contain the antinutritional factors, phytates and tannins, 
which interfere with iron bioavailability [7, 8, 9, 10]. However, recent evidence indicates that 
individuals may adapt to the negative effects of phytates [11]. In support of this finding was an 
adaptive response that led to higher iron absorption from low bioavailable diet and lower 
absorption from high bioavailable diet in iron-replete men [12]. 
Extrusion is a food processing technique that cooks food using high temperature under 
high pressure for a short period of time in combination with moisture and mechanical shear [13]. 
The desirable effects of this cost-effective method are that it decreases viscosity, increases 
palatability, increases digestibility, and partial or total destruction of anti-nutritional factors that 
leads to improved iron bioavailability [14, 15].  
Hence, for the current project we developed extrusion cooked novel sorghum-cowpea 
blend (SCB) sorghum-soy blend (SSB) and corn-soy blend (CSB) FBFs following the 
recommendations provided for new FBFs [4] and USDA commodity requirements [16, 17]. 
Traditional non-extruded FBFs; CSB13 and CSB+ were procured to use as comparisons to the 
newly developed FBFs. The purpose of this study was to assess the bioavailable iron levels of 
newly developed extruded SCB, SSB and CSB FBFs compared to traditional non-extruded 
FBFs; CSB13 and CSB+ in the in-vitro digestion-Caco-2 cell model. The in-vitro digestion-
Caco-2 model is a widely used model to study the bioavailability of nutrients from foods and 
supplements [18-22]. It has been successfully used to screen different varieties of 
complementary foods [23], lentils [24], and grains like wheat [25].  This model is a cost-effective 
alternative to in-vivo studies to assess iron bioavailability that is superior to iron solubility and 
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dialyzability methods [26]. To the best of our knowledge, the bioavailable iron levels of FBFs 
has not been investigated before.  
 Materials and Methods 
 Chemicals 
Unless stated otherwise, all the reagents used in the experiment were purchased from 
Sigma-Aldrich Corp (St. Louis, MO, USA) and Fisher Scientific (Pittsburgh, PA, USA). 
 FBF formulations 
Extruded sorghum-cowpea (n=7), sorghum-soy (n=4) and corn-soy (n=3) were formulated based 
on FAQR requirements [4] (Table 2-1). Two white (Fontanelle 4575, 738Y) and one red (217X 
Burgundy) (Delimont et al, manuscript in preparation) sorghum varieties whole or decorticated, 
were used in making extruded sorghum-cowpea FBFs. Cowpea flour was sourced commercially.  
For extruded sorghum-soy FBFs; white sorghum variety 1 (Fontanelle 4575), whole or 
decorticated, with low-fat (1.85%) or medium-fat (6.94%) or full-fat (16.93%) soybeans were 
used. For extruded corn-soy FBFs; whole or degermed corn with medium- and full-fat soybeans 
were used. The other ingredients; sugar, oil, whey protein concentrate with 80% protein content 
(WPC 80) and vitamin-mineral premix were added after extrusion to prevent destruction of 
micronutrients in the mix. The premix that we used provided lower levels of vitamins A, D and E 
than the FAQR recommended (Table 2-2).  Both the non-extruded FBFs; CSB13 and CSB+ were 
produced by Bunge Milling (St. Louis, MO) according to the USDA commodity requirements 
[16, 17]. The major difference between these two is that, CSB+ is a more recent and enhanced 
form of CSB13 with improved micronutrient formulation [27]. Cerelac (Nestle, NJ), a 
commercially available fortified infant food, was purchased from a local store and used as the 
reference control as has been done previously [23]. The fortification form of iron, was different 
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between extruded and non-extruded FBFs. Ferrous sulfate (FeSO4) and sodium iron EDTA 
(NaFeEDTA) were added in the extruded FBFs,  whereas ferrous fumarate and NaFeEDTA were 
present in CSB+ and only ferrous fumarate was present in CSB13. All the FBFs were stored at -
20°C in zip lock bags covered with aluminum foil.   
 FBF porridge preparation 
To prevent iron contamination, glassware used in the sample preparation, in-vitro 
digestion and iron analysis was acid washed by soaking in 5% nitric acid solution for no less 
than 12 hours and rinsing with double-deionized water before use. Twenty grams of dry FBF or 
Cerelac was slowly added to 80 g of boiling water in a beaker on a hot plate and stirred 
vigorously for 2 min, removed from hot plate and stirred for another minute. Non-extruded 
CSB13 and CSB+ were prepared in a similar manner using 11.75 g and 13.79 g dry FBF instead 
and cooked for 10 min on a hot plate following the preparation instructions for CSB13 and 
CSB+. FBF porridge was then covered with aluminum foil and kept in water bath at 37°C for 10 
min to prevent skin formation. FBF porridge was weighed and water lost during preparation was 
added back in to bring the final weight to 100 g.  
Following cooking, Cerelac and FBF porridges were transferred to 50ml polypropylene 
tubes, covered in aluminum foil, blanketed with nitrogen, sealed and stored at -80°C. FBFs were 
cooked in duplicates on two different days. Later, these two sets of porridge were used for 
different in-vitro digestion/Caco-2 cell experiments.  
 Dry FBF and aqueous fraction iron determination  
Dry FBF and aqueous fraction iron content were analyzed by atomic absorption 
spectrophotometer (AAS). Dry FBF and Cerelac iron concentration was analyzed (AACC 40-70, 
1999) by AIB international analytical services (Manhattan, KS). Briefly, ten grams of the sample 
44 
was taken in ashing vessels and dried to ash overnight at 500°C in muffle furnace. Residue was 
dissolved in 10 ml of concentrated HCl, boiled and evaporated to near dryness on a hot plate. 
Resulting residue was redissolved in 20 ml of 2N HCl, filtered and diluted to 100 ml with water. 
Iron concentrations were then measured on atomic absorption spectrophotometer. For aqueous 
fraction iron concentrations, filtered samples were directly measured on an AAS (Perkin Elmer, 
AAnalyst 100). 
 In-vitro digestion 
Aliquots of Cerelac, extruded and non-extruded FBF porridges were subjected to in-vitro 
digestion as described previously [28].Two and half grams of thawed FBF was weighed into a 
beaker and 10 ml of basal salt solution (120 mmol/L NaCl, 5 mmol/L KCl, 6 mmol/L CaCl2) was 
added, homogenized with a laboratory homogenizer (Omni GLH, Kennesaw, GA) for 2 min, and 
then mixed on a magnetic stir plate for 5 min. Ten ml aliquots of homogenized FBFs were 
subjected to a three phase in-vitro digestion consisting of 10 min oral, 1 hour gastric and 2 hour 
intestinal digestion. 
 
 Oral digestion 
Stock saliva solution containing 0.9 mg KCl, 0.89 mg NaPO4, 0.57 mg NaSO4, 0.3 mg 
NaCl and 1.69 mg NaHCO3 /ml deionized water was prepared and used for all the experiments. 
Artificial saliva solution was prepared by adding uric acid (0.015 mg/ml), urea (0.2 mg/ml), 
mucin (0.025 mg/ml) and α–amylase (10.55 mg/ml) to stock saliva solution just before use. Ten 
ml of homogenized FBF solution was added to a 50 ml conical tube and 8 ml of freshly prepared 
artificial saliva was added. Tubes were mixed well, blanketed with nitrogen, sealed with parafilm 
and incubated in shaking water bath at 37°C, 85 rpm for 10 min.  
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 Gastric digestion 
 After oral digestion, pH was decreased to 2.5 ± 0.1 by slowly adding 1M HCl. Then 2 ml 
of freshly made pepsin solution (40 mg/ml in100 mM HCl) was added to each tube. The final 
volume was adjusted to 40 ml with basal salt solution, blanketed with nitrogen, sealed with 
parafilm and incubated in shaking water bath at 37°C, 85 rpm for 1 hour. The gastric phase was 
terminated by increasing pH to 6.0 ± 0.1 with 1M NaHCO3 and placing the tubes on ice. 
 Small intestinal digestion 
After terminating gastric digestion, 2 ml of pancreatin (10 mg/ml in 100mM NaHCO3) 
and lipase (5 mg/ml in 100mM NaHCO3) solution and 3 ml of bile extract (40 mg/ml 100mM 
NaHCO3) solution were added to each tube and pH was adjusted to 6.5 ± 0.1 with 1 M NaOH. 
The final volume was adjusted to 50 ml with basal salt solution, blanketed with nitrogen, sealed 
with parafilm and incubated in shaking water bath at 37°C, 85 rpm for 2 hours. 
 Isolation of aqueous fraction from digesta 
After small intestinal digestion, 10 ml aliquots of digesta were transferred to 15 ml 
polypropylene tubes and centrifuged at 5000g for 45 min at 5°C. Supernatant aqueous fraction 
was collected by puncturing the side of the tube with an 18 gauge needle and 10 ml syringe 
without disturbing the pellet at the bottom of the tube. Aqueous fractions were filtered using 0.22 
µm syringe filters (SLGP 033 RS, Millipore, MA), and fresh filtrate was used to treat the Caco-2 
cells. Aliquots of filtered aqueous fraction were blanketed with nitrogen and stored in the dark at 
-80°C for later analysis.  
 Caco-2 cell cultures 
Caco-2 cells (ATCC HTB37) purchased from American Type Culture Collection 
(Manassas, VA) were used in the experiment at passage 40 and 41. The cells were maintained at 
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37°C in an incubator with a 5% CO2/95% humidity, and media was changed every other day. 
Caco-2 cells were initially cultured in growth-enhanced treated T-75 flasks (TP 90076, Midsci, 
MO) in the presence of Dulbecco’s Modified Eagle’s Medium (DMEM, GIBCO, Grand Island, 
NY), supplemented with 15% fetal bovine serum (Atlanta Biologicals, GA), 1% antibiotic/ 
antimycotic (penicillin/streptomycin) solution, 1% L-glutamine, 1% non-essential amino acid 
and 0.2% amphotericin B [28]. Confluent cells were subcultured by incubating with 5 ml of 
0.25% trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA) solution for 5 min, which was 
then inactivated by adding 10 ml of 15% DMEM. Suspended cells were collected into 50 ml 
conical tubes and centrifuged at 800 rpm for 5 min at room temperature. After resuspending and 
counting with a hemocytometer, cells were seeded at 50,000 cells/cm2 in tissue culture treated 6-
well plates (Corning Inc, Corning, NY). After being seeded at day 0, cells were switched from 15 
to 7.5% fetal bovine serum, to slow growth once confluent, usually 4-5 days after seeding. Cells 
were used in the iron bioavailability experiments 14 days post-seeding [29, 30].   
 Aqueous fraction Caco-2 treatment  
A day before the experiment, on day 13, Caco-2 monolayers were supplemented with 
fresh media. On day 14, spent media was removed before treating the cells with 0.25 ml fresh 
aqueous fraction added to 1.75 ml of DMEM. Samples were randomly assigned to wells; Cerelac 
was used as a reference control on each plate. In-vitro digestion and Caco-2 cell culture 
experiments were completed in duplicate on different days using different passage cells. 
 Harvesting Caco-2 monolayers 
After 12 hours of incubation [31, 32], treatments were removed and cells were washed 
with 2 ml of ice cold 2X PBS followed by 2 ml of ice cold 2 g/L EDTA in PBS. Caco-2 
monolayers were scraped with a cell scraper and collected into 10 ml polystyrene tubes using 1 
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ml ice cold deionized water. This process was repeated twice more using 0.5 ml deionized water 
and collected into the same tube for a total of 2 ml of deionized water. Cells in this solution were 
homogenized for 2 min on ice and stored at -20°C for ferritin and protein determination that was 
completed within 24 hours [33, 22]. 
 Caco-2 cell ferritin and protein determination  
Ten µl cell homogenates were used for determining ferritin concentrations (ng/ml) using 
an enzyme-linked immunosorbent assay (ELISA) (Spectro Ferritin kit, S-22, Ramco 
Laboratories Inc., Stafford, TX) as done previously [24, 33]. Twenty five µl cell homogenates 
were used for measuring protein concentrations using Pierce bicinchoninic acid protein assay kits 
(Rockford, IL). Ferritin content (ng/mg cell protein) was calculated as a ratio of cell ferritin 
(ng/ml) / cell protein (mg/ml) [33].  
 Statistical analysis 
Data were analyzed using one-way ANOVA with Tukey’s test on SAS 9.3 (SAS Institute 
Inc., Cary, NC, USA), with p < 0.05 considered significant. Natural logs were used to transform 
data that did not meet the model assumptions.  
 
 Results 
 Iron concentration in dry FBF and aqueous fraction   
Iron concentration in dry FBFs ranged from 8.0 to 31.8 mg/100g and iron levels in 
aqueous fractions ranged from 2.1 to 8.5 µg/10 ml (Table 2-3). The mean iron concentrations in 
extruded dry FBFs was higher than CSB+, but lower than CSB13. Whole white sorghum 2-
cowpea FBF had higher dry FBF iron levels compared to all other FBFs except CSB13. All 
extruded FBFs had significantly higher levels of iron in aqueous fractions compared to CSB13 
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with the exception of whole corn-soy (medium fat) FBF. Also, extruded FBFs had significantly 
higher aqueous fraction iron levels compared to CSB+ with the exception of decorticated 
sorghum-soy (medium-fat) and whole corn-soy (medium fat) FBFs. There was no difference in 
aqueous fraction iron levels between CSB13 and CSB+.   
 Ferritin concentration in Caco-2 cells treated with different FBFs 
There were no significant differences in ferritin levels between extruded and non-
extruded FBFs (Table 2- 4). There also was no significant difference between basal salt solution 
alone (negative control) and FBF treatments on ferritin concentrations.  
 
 Discussion 
All fourteen extruded FBFs were supplemented with iron 13mg iron/100g dry mix in the 
ratio of 11 mg iron from ferrous sulfate (FeSO4) and 2 mg iron from sodium iron EDTA 
(NaFeEDTA). However, iron analysis showed differences in dry mix iron levels for some of the 
FBFs. These differences are most likely due to differences in intrinsic grain iron content. All of 
the whole sorghum-cowpea FBFs, and most of the whole sorghum-soy FBFs had slightly higher 
iron levels compared to their corresponding decorticated FBFs. As iron is distributed in different 
regions of the grain including the outer layers, it is not surprising that decortication or dehulling 
results in lower iron levels [34, 35]. Of the non-extruded FBFs, CSB13 had 2-fold higher iron 
levels (31.8 mg/100g) and CSB+ had 2-fold lower iron (8.0 mg/100g) levels compared to the 
extruded FBFs. Both CSB13 and CSB+ were procured from millers that prepared these FBFs 
following the USDA commodity requirements [16, 17], that require that CSB13 should contain 
14.7 to 30.0 mg/100g iron and CSB+ should contain 9.0 to 21.0 mg/100g iron. Iron levels in 
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CSB13 were slightly higher than the upper limit, whereas CSB+ iron levels were slightly lower 
than the lower limit set by USDA. 
All of the extruded FBFs contained 2- to 4-fold significantly higher aqueous fraction iron 
levels compared to CSB13 and CSB+ with the exception of whole corn-soy (medium fat) vs 
CSB13 and decorticated sorghum-soy (medium-fat) and whole corn-soy (medium fat) vs CSB+. 
One of the reasons for the low aqueous fraction iron concentration in CSB13 and CSB+ may be 
that extruded FBFs were cooked using 20% solids, whereas, CSB13 and CSB+ porridges were 
cooked using 11.75% and 13.79% solids. Another possibility is that the extrusion cooking 
reduced the anti-nutrient content [14, 36], thereby improved extruded FBFs’ aqueous fraction 
iron levels. There was no difference in aqueous fraction iron levels between CSB13 and CSB+ in 
spite of a 4-fold higher iron in dry CSB13 FBF. CSB+ is an improved formulation of CSB13 
with enhanced nutrient profile and with ingredients partially cooked through dry roasting [17]. 
This heat processing might have contributed to improved aqueous fraction iron levels in CSB+, 
like in previous studies that observed 16-32% increase in iron availability with roasting and 
malting [37]. Another reason for the improved iron availability might be that CSB+ is fortified 
with both ferrous fumarate and NaFeEDTA, the latter iron fortificant chelates with native iron in 
the diet and protects it from iron binding ANF [38, 39, 40]. 
Treatment with both extruded and non-extruded FBFs resulted in similar ferritin levels in 
the in-vitro digestion Caco-2 model. The mean ferritin concentrations ranged between 45.0-58.9 
ng/mg. The ferritin values are similar to a previous study that observed 6.58-72.38 ng/mg in 
different wheat flours [41]. The amount of iron added to Caco-2 cells ranged from 0.05-0.21 
µg/well, which was similar range levels (0.05-0.39 µg/well) found in different rice varieties that 
also did not find significant differences in ferritin levels [21]. Also, no differences were observed 
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in ferritin concentration between cells treated with basal salt solution and FBF aqueous fractions. 
Previous studies have also found ferritin levels that were not different from baseline levels [42, 
43]. However, in Glahn et al (2002) study, after adding ascorbic acid, iron bioavailability of the 
rice sample significantly increased beyond the baseline levels [21]. It should be noted that 
extruded FBFs are fortified with 40 mg/100g ascorbic acid, and CSB13 and CSB+ are fortified 
with 40 mg/100g and 90 mg/100g ascorbic acid, respectively. However, we did not add 
exogenous ascorbic acid in our experiments. 
The aqueous fraction iron levels used to treat the Caco-2 cells were not correlated to 
ferritin synthesis as has found previously [33, 22, 21]. One possibility is that the aqueous fraction 
iron may bind to low molecular weight phytates, making it unavailable for uptake and ultimately 
ferritin synthesis [44].  
Some studies have achieved significant ferritin response by increasing the food sample 
quantity. Eagling et al (2014), increased the sample quantity from 0.5g to 1g and then to 3g due 
to low ferritin response with lower amounts (< 3g) of food [25]. For our experiment, we used 
only 2g porridge, as > 2g resulted in thick sample that did not digest well.  It should be noted that 
their unleavened bread flour samples contained very low iron concentrations (0.67-4.67 
mg/100g) compared to our FBF samples (8.0-31.8 mg iron/100g).   
We anticipated that bioavailable iron may be higher in decorticated sorghum FBFs 
compared to corresponding whole FBFs because ANF localized in the outer layers of the grains 
will be lost during decortication [35]. In tannin-containing Seredo variety of sorghum, 
decortication by mechanical abrasion reduced the tannin content by 82% [45]. In another study 
with both tannin and non-tannin sorghum varieties, decortication reduced tannins by 79-92% 
[36]. However, ferritin concentrations of FBFs were not different between whole and 
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decorticated sorghum-cowpea blends. On the other hand, we observed a slight increase in ferritin 
response for decorticated sorghum-soy FBF (52.2 ng/mg) and degermed corn-soy FBF (51.2 
ng/mg) compared to their corresponding whole FBFs with ferritin response 47.9 ng/mg and 47.3 
ng/mg respectively. 
It is difficult to compare in-vitro digestion/Caco-2 model iron bioavailability studies due 
to methodological differences. Some studies used two chamber arrangement with dialysis 
membrane [46, 47, 21, 48], while others treated the Caco-2 cells directly with aqueous fraction 
[33, 22, 49]. Other studies have grown cells on inserts to allow study of the iron transport across 
the Caco-2 monolayer [50]. Even though the Caco-2 cell density/well (50,000 cells/cm2) is 
similar in majority of the studies, the day cells were used for bioavailability experiment varies. 
Some studies used cells grown on 6-well or 12-well plates 13 days post-seeding [25, 44], others 
used cells between a range of 14-16 days post-seeding [22]. In addition to the above mentioned 
differences, presentation of iron bioavailability data greatly varied among studies. Some authors 
provided iron bioavailability as a percent of control sample or FeSO4 positive control [50, 41, 51, 
49], whereas others provided actual ferritin values [23-25, 33].  
The major limitation of our study was that we did not observe a greater ferritin response 
with our samples. However, many of the iron bioavailability studies also did not observe above 
baseline ferritin response [42, 43]. Our study also lacks specific information about levels of 
antinutritional factors in FBFs such as phytates and tannins that have direct relevance to iron 
bioavailability. Study results should be extrapolated with caution, because previous study with 
red and white beans that observed little ferritin response in Caco-2 cells, found significant 
improvements in iron status when the same samples were tested in animals [42]. However, a rat 
study conducted by others in our laboratory, extruded sorghum-cowpea, extruded sorghum-soy 
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FBFs and CSB+ showed no significant difference in hemoglobin and liver iron levels (Delimont 
et al, manuscript in preparation), confirming our Caco-2 results of similar iron availability 
among FBFs. In line with our results, Pynaert et al (2006), found significantly higher soluble iron 
in processed compared to unprocessed complementary foods (CF). However the iron 
bioavailability of processed and unprocessed CF was similar due to a proportional decrease in 
Caco-2 cell iron uptake from processed CF [52]. In a previous clinical study conducted with the 
same complementary foods, no difference in iron status was observed in infants fed processed 
and unprocessed CF [53]. 
In conclusion, our study results suggest that consumption of newly developed extruded 
sorghum-cowpea, sorghum-soy and corn-soy FBFs will result in iron status comparable to 
traditional non-extruded CSB13 and CSB+ FBFs. Our results also indicate the need for future 
studies looking at the reasons for poor in-vitro iron bioavailability of FBFs. 
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Table 2-1 Composition of extruded FBFs and non-extruded FBFs. 
Ingredients (%) SCB SSB CSB CSB13 CSB+ 
Sorghum Flour  24.7 47.6    
Cowpea Flour 38.6     
Corn flour   48.1   
Corn (White or Yellow)     78.5 
Cornmeal    69.5  
Whole Soybeans     20.0 
Soy Flour  15.7 15.2   
Soy Flour, defatted    21.9  
Soybean oil, Refined    5.5  
Sugar 15.0 15.0 15   
Whey Protein Concentrate (WPC80) 9.5 9.5 9.5   
Vegetable Oil  9.0 9.0 9   
Vitamin & Mineral Premix 3.2 3.2 3.1   
Minerals    3.0  
Vitamin Antioxidant Premix    0.1  
Vitamin/Mineral     0.2 
Tri-Calcium Phosphate     1.2 
Potassium Chloride     0.2 
† For extruded FBFs; SSB (full-fat soy) and CSB (full-fat soy), WPC80 was increased  
  from 9.5% to 13% and vegetable oil was decreased from 9% to 5.5%. 
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Table 2-2 Macronutrient and micronutrient formulation of FBFs. 
Nutrient in 100g Unit SCB/SSB/CSB CSB 13 CSB+ 
Energy kcal 380 386 380 
Protein g  17 16 14 
Fat g 8 9 6 
Vitamin A† mg 0.120 (0.488) 0.819 1.04 
Thiamin (B1) mg 0.652 0.61 0.2 
Riboflavin (B2) mg 0.933 0.481 1.4 
Niacin (B3) mg 9.07 6.29 8.0 
Pantothenic Acid (B5) mg 3.646 3.285 1.6 
Vitamin B6 mg 0.752 0.532 1.0 
Folic Acid (B9) mg 0.087 0.247 0.11 
Vitamin B12 mg 0.0015 0.001 0.002 
Vitamin D† mg 0.0006 (0.029) 0.005 0.011 
Vitamin E† mg 10.856 (13.22) 0.98 8.3 
Vitamin K mg 0.033 0.001 0.03 
Vitamin C mg 40.0 40.2 90 
Calcium mg 279.08 650 452 
Total Iron (Fe) mg 13.0 10.6 6.5 
Fe (FeSO4) mg 11.0 0.0 4.0 
Fe (NAFeEDTA) mg 2.0 0.0 2.5 
Fe (Ferrous fumarate) mg 0.0 10.6 4.0 
Iodine mg 0.23 0.0 0.04 
Phosphorus mg 290.97 522.0 290.0 
Potassium mg 163.19 563.0 140.0 
Zinc mg 5.5 5.94 5.0 
† For the extruded FBFs, vitamin A, D and E values in the parentheses are the recommendations.  
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Table 2-3 Iron concentration in dry FBF (mean) and aqueous fraction (mean ± SEM) of extruded 
and non-extruded FBFs.  
Cereal Cereal type Legume  Dry FBF 
(mg/100g) 
Aqueous fraction 
(µg/10ml) 
Sorghum-Cowpea blends 
White Sorghum 1 Whole Cowpea 16.8 6.8 ± 1.1ab 
White Sorghum 1 Decorticated Cowpea 15.6 6.4 ± 0.2ab 
White Sorghum 1 Whole, coarse Cowpea 16.4 6.8 ± 0.4ab 
White Sorghum 2 Whole Cowpea 21.1 6.7 ± 0.6ab 
White Sorghum 2 Decorticated Cowpea 16.3 6.6 ± 0.4ab 
Red Sorghum Whole Cowpea 16.8 5.7 ± 0.1ab 
Red Sorghum Decorticated Cowpea 15.9 7.3 ± 0.4ab 
Sorghum-Soy blends 
White Sorghum 1 Whole Low Fat soy 19.5 7.2 ± 0.4ab 
White Sorghum 1 Whole Medium Fat Soy 16.1 8.5 ± 0.3ac 
White Sorghum 1 Decorticated Medium Fat Soy 16.7 5.4 ± 0.1abe 
White Sorghum 1 Whole Full Fat soy 18.2 7.3 ± 0.5ab 
Corn-Soy blends 
Corn Whole Medium Fat Soy 16.1 5.0 ± 0.2bde 
Corn Degermed, coarse Medium Fat Soy 16.1 7.0 ± 0.4ab 
Corn Whole Full Fat soy 16.0 7.4 ± 0.1ab 
CSB13 Corn meal Defatted Soy flour 31.8 2.1 ± 0.1d 
CSB Plus Whole corn Whole soy 8.0 2.4 ± 0.1de 
Within a column, means without a common superscript are significantly different (p<0.05). 
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Table 2-4 Caco-2 cell ferritin levels following aqueous fraction treatment (n=2, mean ± SEM). 
Cereal Cereal type Legume 
Ferritin (ng/mg 
protein) 
Sorghum-Cowpea blends 
White Sorghum 1 Whole Cowpea 54.8 ± 17.3 
White Sorghum 1 Decorticated Cowpea 49.2 ± 7.9 
White Sorghum 1 Whole, Coarse Cowpea 45.0 ± 12.2 
White Sorghum 2 Whole Cowpea 53.3 ± 9.7 
White Sorghum 2 Decorticated Cowpea 55.4 ± 12.3 
Red Sorghum Whole Cowpea 58.2 ± 18.8 
Red Sorghum Decorticated Cowpea 51.5 ± 5.1 
Sorghum-Soy blends 
White Sorghum 1 Whole Low Fat soy 58.9 ± 13.3 
White Sorghum 1 Whole Medium Fat Soy 47.9 ± 4.1 
White Sorghum 1 Decorticated Medium Fat Soy 52.2 ± 12.7 
White Sorghum 1 Whole Full Fat soy 45.2 ± 9.2 
Corn-Soy blends 
Corn Whole Medium Fat Soy 47.3 ± 10.3 
Corn Degermed, Coarse Medium Fat Soy 51.2 ± 8.3 
Corn Whole Full Fat soy 50.4 ± 5.3 
CSB13 Corn meal Defatted Soy flour 48.2 ± 7.4 
CSB+ Whole corn Whole soy 52.6 ± 10.5 
Control sample 
Basal salt solution  52.8 ± 6.9 
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Chapter 3 - Determination of Bioavailable Iron and Vitamin A in 
Sorghum, Cowpea, Corn and Soybean Fortified Blended Foods 
- Cell Lysis Buffer Method 
 
 Abstract 
Background: Fortified blended foods (FBFs), particularly corn-soybean blend (CSB), 
are food aid products distributed in developing countries. In order to improve the FBFs, a United 
States Agency for International Development (USAID) Food Aid Quality Review report 
recommended developing novel FBFs using local alternative commodities such as sorghum and 
improving the nutritional quality of FBFs by using extrusion processing. Given the high 
prevalence of iron and vitamin A deficiency in Africa, and that the continent receives almost 
70% of global food aid, it is important to determine the bioavailable levels of these two 
micronutrients in FBFs. 
Objective: The objective of the study was to determine bioavailable iron and vitamin A 
levels, from these novel, extruded sorghum-cowpea, sorghum-soy and corn-soy FBFs compared 
to the traditional food aid FBFs; corn-soy blend 13 (CSB13) and corn-soy blend plus (CSB+).  
Methods: Eleven extruded FBFs; sorghum-cowpea (n=7), sorghum-soy (n=3) and corn-soy 
(n=1), two non-extruded FBFs; CSB13 and CSB+, and Cerelac, a commercial infant cereal, were 
prepared as porridges, and bioavailable iron and vitamin A levels were assessed using the in-
vitro digestion/Caco-2 cell model by measuring Caco-2 cell ferritin (ng ferritin/mg cell protein) 
and vitamin A (µg /g cells) levels in response to 12-hour and 4-hour treatments, respectively, 
with aqueous fractions from digested FBFs. Cerelac was used as a control on each plate. Control 
cells collected at time zero, 0.1 and 0.2 µg iron ferrous sulfate (FeSO4) solutions, and basal salt 
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solution (BSS), were used as baseline, positive, and negative controls, respectively. Dry FBF 
iron concentrations were measured using a atomic absorption spectrophotometer (AAS). Vitamin 
A was extracted from dry FBFs, aqueous fractions and Caco-2 cell pellets and analyzed using 
HPLC. 
Results: Ion and vitamin A content in Cerelac and dry FBFs ranged from 8.0 to 31.8 
mg/100g and 0.3 to 1.67 mg/100g, respectively. All of the extruded FBFs contained 4- to 7-fold 
significantly higher (p<0.05) aqueous fraction iron concentrations compared to CSB13 and 
CSB+. There were no significant differences in aqueous fraction vitamin A content. There were 
no significant differences in Caco-2 cell ferritin and vitamin A levels between extruded FBFs, 
non-extruded FBFs, nor the basal salt solution control. Iron sulfate (FeSO4) positive control 
treatments significantly increased (p<0.05) ferritin levels compared to all FBFs except CSB+ and 
CSB14. 
Conclusions: The significant differences in aqueous fraction iron in extruded compared to non-
extruded FBFs did not result in similar responses in Caco-2 cells after treatment. Our results 
support that consumption of newly developed extruded sorghum-cowpea, sorghum-soy and corn-
soy FBFs will result in bioavailable iron and vitamin A levels comparable to traditional non-
extruded CSB13 and CSB+ FBFs. Thus, an extruded sorghum-cowpea FBF may be a suitable 
alternative to corn-soybean based FBFs. 
 Introduction 
In food aid recipients in Africa, iron deficiency anemia (IDA) and vitamin A deficiency 
are the most prevalent micronutrient deficiencies [1]. Both IDA and vitamin A deficiency are the 
nutritional problems of public health significance affecting most of the women and children 
throughout the world [2]. Globally, more than 2 billion people are at risk for vitamin A, iodine 
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and iron deficiencies with higher prevalence in Southeast Asia and sub-Saharan Africa. More 
than one micronutrient deficiency exists in most of the settings, indicating the need to address 
multiple micronutrient deficiencies [3].   
Fortified blended foods (FBFs) are porridge mixes composed of cereals and legumes that 
have been milled, blended and fortified with vitamins and minerals, that are the major food aid 
products for young children, women and other vulnerable groups in developing countries. Corn-
soy blend (CSB) is the most widely distributed FBF in a majority of the food aid receiving 
countries [4]. A United States Agency for International Development (USAID) food aid quality 
review (FAQR) recommended developing novel FBFs using cereals that are both culturally and 
nutritionally acceptable in Africa. It recommends sorghum as an alternative to corn or wheat 
(FAQR recommendation 18) [5]. Cowpea is a legume that may also be beneficial component of 
FBFs. Both sorghum and cowpea are drought-tolerant, sustainable and cost-effective.  
Sorghum and cowpea are rich in iron, complement each other by providing the limiting 
amino acids lysine and cysteine missing from the other commodity, which improves protein 
quality [6, 7]. Sorghum and cowpea contain the antinutritional factors, phytates and tannins, 
which interfere with iron bioavailability [8-11]. However, recent evidence indicates that 
individuals may adapt to the negative effects of phytates [12]. In support of this finding was an 
adaptive response that led to higher iron absorption from low bioavailable diet and lower 
absorption from high bioavailable diet in iron-replete men [13]. 
Extrusion is a food processing technique that cooks food using high temperature under 
high pressure for a short period of time in combination with moisture and mechanical shear [14]. 
The desirable effects of this cost-effective method are that it decreases viscosity, increases 
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palatability, increases digestibility, and partial or total destruction of anti-nutritional factors that 
leads to improved iron bioavailability [15, 16].  
For the current project, we developed extruded novel sorghum-cowpea blend (SCB) 
sorghum-soy blend (SSB) and corn-soy blend (CSB) FBFs based on the new FBF 
recommendation [5] and USDA commodity requirements [17, 18]. Traditional non-extruded 
FBFs; CSB13 and CSB+ were procured to use as comparisons for the newly developed FBFs. 
The purpose of this study was to assess the in-vitro bioavailable iron and vitamin A levels of 
newly developed extruded SCB, SSB and CSB FBFs compared to traditional non-extruded 
FBFs; CSB13 and CSB+ in the in-vitro digestion/Caco-2 cell model. The in-vitro digestion 
Caco-2 model is a widely used, simple and inexpensive model to study the bioavailability of 
nutrients from foods and supplements [19-23]. It has been successfully used to screen different 
varieties of complementary foods [24], lentils [25], wheat [26], cassava [27] and supplemented 
food stuffs [28].  This is the first study to develop novel sorghum based FBFs, and to the best of 
our knowledge, both iron and vitamin A in-vitro bioavailability of FBFs has not been assessed 
previously.  
 
 Materials and Methods 
 Chemicals 
Unless stated otherwise, all the reagents used in the experiment were purchased from 
Sigma-Aldrich Corp (St. Louis, MO, USA) and Fisher Scientific (Pittsburgh, PA, USA). Water 
used for porridge preparation, in-vitro digestion, reagent preparation and vitamin A extraction 
was double deionized. To prevent iron contamination, glassware used in the sample preparation, 
in-vitro digestion and iron analysis were acid washed by soaking in 5% nitric acid solution for no 
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less than 12 hours and rinsing with double deionized water before use. HPLC grade acetonitrile, 
methanol, chloroform, hexane and ethanol were used. 
 FBF formulations 
Extruded sorghum-cowpea (n=7), sorghum-soy (n=3) and corn-soy (n=1) were formulated based 
on FAQR requirements [5] (Table 3-1). Two white (Fontanelle 4575, 738Y) and one red (217X 
Burgundy) sorghum varieties, whole or decorticated, were used in making extruded sorghum-
cowpea FBFs (Delimont et al, manuscript in preparation). Cowpea flour was sourced 
commercially. For extruded sorghum-soy FBFs; white sorghum variety 1 (Fontanelle 4575), 
whole or decorticated, with low-fat (1.85%) medium-fat (6.94%) or full-fat (16.93%) soybeans 
were used. For extruded corn-soy FBFs; whole or degermed corn with medium- and full-fat 
soybeans were used. The other ingredients; sugar, oil, whey protein concentrate with 80% 
protein content (WPC 80) and vitamin-mineral premix were added after extrusion to prevent 
destruction of micronutrients in the mix (Table 3-2).  Both the non-extruded FBFs; CSB13 and 
CSB+ were produced by Bunge Milling (St. Louis, MO) according to the USDA commodity 
requirements [17, 18]. The major difference between these two is that, CSB+ is a more recent 
and processed form of CSB13 with improved micronutrient formulation [29]. Cerelac (Nestle, 
NJ), a commercially available fortified infant food, was purchased from a local store and used as 
the reference control as has been done previously [24]. The fortification form of iron and 
vitamins A were different between Cerelac, extruded and non-extruded FBFs. Retinyl palmitate 
was added in extruded and non-extruded FBFs, whereas retinyl acetate was added in the Cerelac. 
For iron, ferrous sulfate (FeSO4) and sodium iron EDTA (NaFeEDTA) were added in the 
extruded FBFs, whereas ferrous fumarate and NaFeEDTA was added in CSB+ and only ferrous 
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fumarate was added in CSB13 and Cerelac. All the FBFs were stored at -20°C in zip lock bags 
covered with aluminum foil.   
 FBF porridge preparation 
Twenty grams of dry FBF or Cerelac was slowly added to 80 g of boiling water in a 
beaker on a hot plate and stirred vigorously for 2 min, removed from hot plate and stirred for 
another minute. Non-extruded CSB13 and CSB+ were prepared in a similar manner but 11.75 g 
and 13.79 g dry FBF, respectively, was used and they were cooked for 10 min on a hot plate with 
11.75 g and 13.79 g dry FBF, respectively. These changes were made following the preparation 
instructions for CSB13 and CSB+ [17, 18]. FBF porridge was then covered with aluminum foil 
and kept in water bath at 37°C for 10 min to prevent skin formation. FBF porridge was weighed 
and water lost during preparation was added back in to bring the final weight to 100 g.  
Following cooking, Cerelac and FBF porridges were transferred to 50 ml polypropylene 
tubes, covered in aluminum foil, blanketed with nitrogen, sealed and stored at -80°C until 
analysis. FBFs were cooked in duplicates on two different days. Later, these two sets of porridge 
were used for in-vitro digestion/Caco-2 cell experiments.  
 In-vitro digestion 
Aliquots of Cerelac, extruded and non-extruded FBF porridges were subjected to in-vitro 
digestion as described previously [30].Two and half grams of thawed FBF was weighed into a 
beaker and 10 ml of basal salt solution (120 mmol/L NaCl, 5 mmol/L KCl, 6 mmol/L CaCl2) was 
added, homogenized with a laboratory homogenizer (Omni GLH, Kennesaw, GA) for 2 min, and 
then mixed on a magnetic stir plate for 5 min. Ten ml aliquots of homogenized FBFs were 
subjected to a three phase in-vitro digestion consisting of 10 min oral, 1 hour gastric and 2 hour 
intestinal digestion. 
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 Oral digestion 
Stock saliva solution containing 0.9 mg KCl, 0.89 mg NaPO4, 0.57 mg NaSO4, 0.3 mg 
NaCl and 1.69 mg NaHCO3 /ml deionized water was prepared and used for all the experiments. 
Artificial saliva solution was prepared by adding uric acid (0.015 mg/ml), urea (0.2 mg/ml), 
mucin (0.025 mg/ml) and α–amylase (10.55 mg/ml) to stock saliva solution just before use. Ten 
ml of homogenized FBF solution was added to a 50 ml conical tube and 8 ml of freshly prepared 
artificial saliva was added. Tubes were mixed well, blanketed with nitrogen, sealed with parafilm 
and incubated in shaking water bath at 37°C, 85 rpm for 10 min.  
 Gastric digestion 
 After oral digestion, pH was decreased to 2.5 ± 0.1 by slowly adding 1M HCl. Then 2 ml 
of freshly made pepsin solution (40 mg/ml in100mM HCl) was added to each tube. The final 
volume was adjusted to 40 ml with basal salt solution, blanketed with nitrogen, sealed with 
parafilm and incubated in a shaking water bath at 37°C, 85 rpm for 1 hour. The gastric phase was 
terminated by increasing pH to 6.0 ± 0.1 with 1M NaHCO3 and placing the tubes on ice. 
 
 Small intestinal digestion 
After terminating gastric digestion, 2 ml of pancreatin (10 mg/ml in 100mM NaHCO3) 
and lipase (5 mg/ml in 100mM NaHCO3) solution and 3 ml of bile extract (40 mg/ml 100mM 
NaHCO3) solution were added to each tube and pH was adjusted to 6.5 ± 0.1 with 1 M NaOH. 
The final volume was adjusted to 50 ml with basal salt solution, blanketed with nitrogen, sealed 
with parafilm and incubated in shaking water bath at 37°C, 85 rpm for 2 hours. 
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 Isolation of aqueous fraction from digesta 
After small intestinal digestion, 10 ml aliquots of digesta were transferred to 15 ml 
polypropylene tubes and centrifuged at 5000g for 45 min at 5°C. Supernatant aqueous fraction 
was collected by puncturing the side of the tube with an 18 gauge needle and 10 ml syringe 
without disturbing the pellet at the bottom of the tube. Aqueous fractions were filtered using 0.22 
µm syringe filters (SLGP 033 RS, Millipore, MA), and the fresh filtrate was used to treat the 
Caco-2 cells. Aliquots of filtered aqueous fraction were blanketed with nitrogen and stored in the 
dark at -80°C for later analysis.  
 Dry FBF and aqueous fraction iron determination  
Dry FBF and aqueous fraction iron content was analyzed by atomic absorption 
spectrophotometer (AAS). Dry FBF and Cerelac iron levels was analyzed (AACC 40-70, 1999) 
by AIB International Analytical Services (Manhattan, KS). Briefly, ten grams of sample was 
taken in ashing vessels and dried to ash overnight at 500°C in a muffle furnace. Residue was 
dissolved in 10 ml of concentrated HCl, boiled and evaporated to near dryness on a hot plate. 
Resulting residue was redissolved in 20 ml of 2N HCl, filtered and diluted to 100 ml with water. 
Iron concentrations were then measured on an atomic absorption spectrophotometer. Aqueous 
fraction iron concentrations, filtered samples were directly measured on an AAS (Perkin Elmer, 
AAnalyst 100). 
 Caco-2 cell cultures 
Caco-2 cells (ATCC® HTB37™) purchased from American Type Culture Collection 
(Manassas, VA) were used in the experiment at passage 32 and 33. The cells were maintained at 
37 °C in an incubator with a 5% CO2/95% humidity, and media was changed every other day. 
Caco-2 cells were initially cultured in growth-enhanced treated T-75 flasks (TP 90076, Midsci, 
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MO) in the presence of Dulbecco’s Modified Eagle’s Medium (DMEM, GIBCO, Grand Island, 
NY), supplemented with 15% fetal bovine serum (Atlanta Biologicals, GA), 1% antibiotic/ 
antimycotic (penicillin/streptomycin) solution, 1% L-glutamine, 1% non-essential amino acid 
and 0.2% amphotericin B [30]. Confluent cells were subcultured by incubating with 5 ml of 
0.25% trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA) solution for 5 min, which was 
then inactivated by adding 10 ml of 15% DMEM. Suspended cells were collected into 50 ml 
conical tubes and centrifuged at 800 rpm for 5 min at room temperature. After resuspending and 
counting with a hemocytometer, cells were seeded at 50,000 cells/cm2 in tissue culture treated 6-
well plates (Corning Inc, Corning, NY). After being seeded at day 0, cells were switched from 15 
to 7.5% fetal bovine serum, to slow growth once confluent, usually 4-5 days after seeding. Cells 
were used in the iron and vitamin A bioavailability experiments 14 days post-seeding [31, 32].   
 Aqueous fraction Caco-2 treatment for bioavailable iron experiment 
A day before the experiment, on day 13, Caco-2 monolayers were supplemented with 
fresh media. On day 14, spent media was removed before treating the cells with 0.25 ml fresh 
aqueous fraction added to 1.75 ml of DMEM. Samples were randomly assigned to wells; Cerelac 
was used as a reference control on each plate. A negative control with 0.25 ml of basal salt 
solution containing no iron and 1.75 ml of DMEM was used to treat Caco-2 cells. A positive 
control was prepared with 100 mg of FeSO4.7H2O in 100ml of basal salt solution. This was serial 
diluted to provide 100 µg/ml. Cells were treated with 5 µl or 10 µl  of the diluted FeSO4 solution 
to provide 0.1 µg iron/well or 0.2 µg iron/well. In-vitro digestion and Caco-2 cell culture 
experiments were completed in duplicate on different days using different passage cells. 
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 Harvesting Caco-2 monolayers for ferritin determination 
After 12 hours of incubation [33, 34], treatments were removed and cells were washed 
with 2 ml of ice cold PBS. Caco-2 monolayers were lysed by adding 350 µl/well of mammalian 
protein extraction reagent (M-PER, Thermo Fisher Scientiﬁc, Rockford, IL) [35] and incubated 
in 6-well plates for 10 minutes on a plate shaker at 120 rpm. Caco-2 monolayers were scraped 
with a cell scraper (Fisher Scientific, Pittsburgh, PA), collected into microcentrifuge tubes, 
sonicated for 3 minutes and centrifuged at 14,000g for 10 minutes. Cell lysate supernatants were 
transferred to other tubes and stored at -20°C for ferritin and protein determination that was 
completed within 24 hours [35, 36, 23]. 
 Caco-2 cell ferritin and protein determination  
Ten µl cell lysate solutions were used for determining ferritin concentrations (ng/ml) 
using enzyme-linked immunosorbent assay (ELISA) (Spectro Ferritin kit, S-22, Ramco 
Laboratories Inc., Stafford, TX) as done previously [25, 36]. Twenty five µl cell lysate solutions 
were used for measuring protein concentrations using Pierce bicinchoninic acid protein assay kits 
(Rockford, IL). Ferritin content (ng/mg cell protein) was calculated as a ratio of cell ferritin 
(ng/ml)/cell protein (mg/ml) [36].  
 Aqueous fraction Caco-2 treatment for bioavailable vitamin A experiment 
A day before the experiment, Caco-2 monolayers were supplemented with fresh media. 
On the day of the experiment, spent media was removed before treating the cells with 0.5 ml 
fresh aqueous fraction added to 1.5 ml of DMEM. Samples were randomly assigned to wells; 
Cerelac was used as a reference control on each plate. In-vitro digestion and Caco-2 cell culture 
experiments were completed in duplicate on different days using different passage cells. Control 
cells were collected at time zero without any food treatment. 
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 Harvesting Caco-2 monolayers for vitamin A assessment 
After 4 hours of incubation [37, 28, 27] treatments were removed and cells were washed 
with 2 ml of ice cold 2X PBS followed by 2 ml of ice cold 2 g/L albumin in PBS. Caco-2 
monolayers were scraped with a cell scraper (Fisher Scientific, Pittsburgh, PA), and collected 
into amber colored microcentrifuge tubes using 1 ml ice cold PBS. This process was repeated 
twice more using 0.5 ml ice cold PBS and collected into the same microcentrifuge tube and 
centrifuged at 2000 rpm for 45 minutes at 5°C. PBS was discarded by carefully inverting the 
microcentrifuge tubes and leaving the cell pellet at the bottom. Microcentrifuge tubes were 
placed upside down for 20 seconds to remove excess moisture. Tubes were then blanketed with 
nitrogen, and stored at -80°C for vitamin A analysis.   
 Extraction of vitamin A in dry FBF, Aqueous fraction and Caco-2 cells  
Vitamin A was extracted from dry FBF, aqueous fraction and Caco-2 cell pellets as 
described previously [38] with modifications. For dry FBF, approximately 1.0 g of dry FBF was 
taken in 50 ml screw cap glass tubes and homogenized in 4 ml of deionized water before adding 
10 ml of ethanol with 0.1% butylated hydroxyltoluene (BHT) and 4 mL of super saturated 
potassium hydroxide (KOH). Samples were vortexed and incubated in a water bath at 70°C for 
30 minutes. The tubes were kept on ice and 6 ml of DI water was added. The samples were 
initially extracted with 10 ml of hexane and repeated twice with 5 ml of hexane. Tubes were 
vortexed briefly each time hexane was added and left on ice to allow the layers separate. Top 
hexane layers were collected into a clean glass tube with pasteur pipette, completely dried in 
vacufuge (Model No, 5301, Eppendorf North America, Hauppauge, NY, USA), reconstituted in 
400 µl of mobile phase and analyzed on HPLC on the same day.  
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For aqueous fractions, 8 ml of the thawed aqueous fraction was extracted with 10 ml of 
ethanol with 0.1% BHT and 4 mL of super saturated KOH in the manner similar to dry FBFs. 
For cell pellets, 2 ml of ethanol with 0.1% BHT and 1 mL of super saturated KOH was added to 
thawed cell pellet and incubated at 70°C for 30 minutes. The tubes were kept on ice and 1 ml of 
DI water was added. Samples were extracted with 5 ml of hexane three times and dried the 
hexane layers in the manner similar to dry FBFs. Reconstituted (in 400 µl mobile phase) aqueous 
fractions and cell pellet samples were syringe filtered using whatman PVDF filter with pore size 
0.45µm (Cat No. 6779-1304, GE Healthcare Biosciences, Pittsburgh, PA, USA) before placing 
in HPLC vials. The values were expressed as mg/100g for dry FBF and ng/ml for aqueous 
fraction. All the Caco-2 cell pellets were weighed before extraction and average pellet weight 
was used to calculate vitamin A (µg) per cell pellet weight (g). 
 HPLC analysis 
A Shimadzu HPLC system (Kyoto, Japan) consisting of a DGU-20A3 built in degasser, a 
LC-20AB solvent delivery pump, a SIL-20ACHT auto-sampler, a CTO-20AC column holding 
oven, a CBM-20A communicator module, and a SPD-M20A Photodiode Array Detector was 
used to analyze samples for retinol. A Waters (Milford, MA) C18 reversed phase column was 
used. The column temperature was maintained at 25°C Data was analyzed using LC Solution 
software (Kyoto, Japan). A mobile phase of methanol/ acetonitrile/chloroform (47:47:6, v/v/v) at 
a ﬂow rate of 1.0 mL/min was used, detection was at 325 nm [39] and data was analyzed using 
LC solution software. Vitamin A peaks were identified and quantified. An external retinyl 
acetate (catalog # 1716002, USP, Rockville, MD, USA) standard curve was used for 
quantification, whose concentration was determined using a spectrophotometer (Jenway 6305, 
Bibby Scientific US, NJ, USA) on the day of analysis. Retinyl acetate stock solution 
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concentration was determined on spectrophotomer (Jenway 6305, Bibby Scientific US, NJ, 
USA) on the day of the experiment. Statistical analysis 
Data were analyzed using one-way ANOVA with Tukey’s test on SAS 9.3 (SAS Institute 
Inc., Cary, NC, USA), with p < 0.05 considered significant. Natural logs were used to transform 
data that did not meet the model assumptions.  
 
 Results 
 Iron concentration in dry FBF and aqueous fraction   
Iron concentration in dry FBFs ranged from 8.0 to 31.8 mg/100g (Table 3-3). Extruded 
dry FBF iron concentrations were higher than CSB+, but lower than CSB13. Among the 
sorghum-cowpea FBFs, iron levels are higher in all the whole sorghum FBFs compared to the 
decorticated varieties. Even in sorghum-soy FBFs, both the whole sorghum varieties had higher 
iron concentrations compared to the decorticated variety. Extruded, degermed corn-soy FBF had 
iron levels that are similar to the decorticated sorghum FBFs. Cerelac iron concentrations are 
lower than all the FBFs except CSB+. 
Iron levels in aqueous fractions ranged from 1.4 to 10.3 µg/10ml (Table 3-3). All 
extruded FBFs had significantly higher levels of iron in aqueous fractions compared to CSB13 
and CSB+. There were no significant differences in aqueous fraction iron levels between 
extruded FBFs. Also, there was no significant difference in aqueous fraction iron levels between 
CSB13, CSB+ and Cerelac. Aqueous fraction iron levels in Cerelac (4.2 µg/10ml) were 
intermediate between extruded and non-extruded FBFs, and were significantly lower compared 
to whole white sorhum1-cowpea, decorticated white sorhum1-cowpea, whole sorghum-soy (low 
fat) and whole sorghum-soy (Full fat) extruded FBFS. 
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 Ferritin concentration in Caco-2 cells treated with aqueous fractions 
There were no significant differences in ferritin levels following treatment with the 
different aqueous fractions. (Table 3-4). However, FeSO4 positive control (0.2 µg iron/well) 
showed significantly higher ferritin response compared to FBFs, Cerelac and negative control.  
There was no significant difference between basal salt solution alone (negative control) and FBF 
treatments on ferritin concentrations. Among the extruded FBFs, corn-soy (medium fat) had 
highest iron uptake (6.78 ng/mg) and whole sorghum-soy (full fat) had lowest iron uptake (4.10 
ng/mg). There was a non-significant dose dependent increase in ferritin response with FeSO4 
positive controls with 0.1 µg and 0.2 µg iron/well.   
 Vitamin A concentration in dry FBF and aqueous fraction   
In dry FBFs, vitamin A concentration ranged from 0.54-1.67 mg/100g, with highest 
concentration in non-extruded FBFs (Table 3-5). CSB+ had the highest vitamin A concentration 
of 1.67 mg/100g, while Cerelac contained the lowest concentration of 0.3 mg vitamin A/100g 
among the studied samples. Whole sorghum-cowpea and whole sorghum-soy FBFs contain 
vitamin A concentrations that are higher than Cerelac. FBFs with whole sorghum had slightly 
higher vitamin A levels compared to their corresponding decorticated sorghum FBFs.  
In aqueous fractions, vitamin A concentrations in all the FBFs and Cerelac are similar. 
However sorghum-cowpea FBFs contain higher levels (50.8-80.1 ng/ml) compared to sorghum-
soy and corn-soy FBFs (33.0-49.1 ng/ml). 
 Vitamin A concentration in Caco-2 cells treated with aqueous fraction  
Vitamin A concentration in Caco-2 cell pellets was not significantly different among the 
samples (Table 3-6). The interesting trend was that red sorghum levels trended lower than white 
sorghum. The white sorghum cowpea blend trended to be higher than the other extruded blends 
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as well.  The vitamin A levels in all the FBFs and Cerelac are higher than the negative control 
levels of 2.03 µg/g, with the exception of red sorghum FBFs and CSB13. Control cells collected 
at time zero without any treatment showed even lower levels of 1.82 µg/g. 
 
 Discussion 
All eleven extruded FBFs were supplemented with iron 13 mg/100g dry mix in the ratio 
of 11 mg iron from ferrous sulfate (FeSO4) and 2 mg iron from sodium iron EDTA (NaFeEDTA) 
(Table 3-2). However, iron analysis showed differences in dry mix iron levels between whole 
and decorticated FBFs (Table 3-3). All of the whole sorghum-cowpea FBFs, and whole 
sorghum-soy FBFs had higher iron levels compared to their corresponding decorticated FBFs. 
As iron is distributed in different regions of the grain, including the outer layers, it is not 
surprising that decortication or dehulling results in lower iron levels [40, 41]. Of the non-
extruded FBFs, CSB13 had approximately 2-fold higher iron levels (31.8 mg/100g) and CSB+ 
had approximately 2-fold lower iron (8.0 mg/100g) levels compared to extruded FBFs average 
iron concentration of 18.0 mg/100g. Both CSB13 and CSB+ were procured from millers that 
prepared these FBFs following the USDA commodity requirements [17, 18], that require that 
CSB13 should contain 14.7 to 30.0 mg/100g iron and CSB+ should contain 9.0 to 21.0 mg/100g 
iron. Iron levels in CSB13 were slightly higher than the upper limit, whereas CSB+ iron levels 
were slightly lower than the lower limit set by USDA. 
All of the extruded FBFs contained 4- to 7-fold significantly higher aqueous fraction iron 
concentrations compared to CSB13 and CSB+ (Table 3-3). One of the reasons for the low 
aqueous fraction iron concentration in CSB13 and CSB+ may be that extruded FBFs were 
cooked using 20% solids, whereas, CSB13 and CSB+ porridges were cooked using 11.75% and 
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13.79% solids. Another possibility is that the extrusion cooking reduced the antrinutritional 
factor concentration [15, 42], thereby improving extruded FBFs’ aqueous fraction iron levels. 
There was no difference in aqueous fraction iron levels between CSB13 and CSB+ in spite of a 
4-fold higher iron in CSB13 dry FBF. CSB+ is an improved formulation of CSB13 with 
enhanced nutrient profile and with ingredients partially cooked through dry roasting [18]. This 
heat processing might have contributed to improved aqueous fraction iron levels in CSB+, like in 
previous studies that observed 16-32% increase in iron availability with roasting and malting 
[43]. Another reason for the improved iron availability may have been that CSB+ is fortified 
with both ferrous fumarate and NaFeEDTA. The latter iron fortificant chelates with native iron 
in the diet and protects it from binding to ANF [44, 45, 46]. 
Treatment with both extruded and non-extruded FBFs resulted in similar ferritin levels in 
the in-vitro digestion-Caco-2 model. However, compared to FeSO4 positive control (0.2 µg 
iron/well), with the exception of CSB+ and corn-soy (medium fat), all other FBFs, Cerelac and 
negative control showed significantly lower ferritin levels. The mean ferritin concentrations 
ranged between 4.1-7.4 ng/mg. Positive controls prepared with FeSO4 solution providing 0.1 µg 
iron/well and 0.2 µg iron/well showed a non-significant dose dependent increase in ferritin 
synthesis of 15.87 ng/mg and 29.65 ng/mg respectively. Proulx & Reddy (2006), also treated the 
cells with FeSO4 solution providing 25 µg iron/well, which is > 100 times higher than our study 
concentrations [47]. However, comparison of our positive control ferritin response with the 
previous study was not possible as they presented results in % relative bioavailability 
considering FeSO4 values as 100%. Also, our FeSO4 control samples were not subjected to in-
vitro digestion, unlike in the previous study. The baseline ferritin, observed with basal salt 
solution treatment was 4.75 ng/mg. In a previous study conducted with red and white beans, the 
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baseline ferritin response was 5.56 ng/mg and all of the sample ferritin responses were at or 
significantly below the baseline level [48]. Seven of the extruded FBFs and one non-extruded 
FBF had ferritin response higher than baseline levels. However none of the FBFs showed 
significantly different ferritin levels.  
The amount of iron added to Caco-2 cells in each well ranged from 0.11-0.25 µg/well, 
which was about similar range levels (0.05- 0.39 µg/well) found in different rice varieties that 
also did not find significant differences in ferritin levels [22]. Also, no differences were observed 
in ferritin concentration of cells treated with basal salt solution containing no iron and with 
digested FBFs. Previous studies have also found ferritin levels that were not different from 
baseline levels [48, 49]. However, in Glahn et al (2002) study, after adding ascorbic acid, iron 
bioavailability of the rice sample significantly increased beyond the baseline levels [22]. It 
should be noted that extruded FBFs are fortified with 40 mg/100g ascorbic acid, and CSB13 and 
CSB+ are fortified with 40 mg/100g and 90 mg/100g ascorbic acid, respectively. However, we 
did not add exogenous ascorbic acid in our experiments. 
The aqueous fraction iron levels used to treat the Caco-2 cells were not correlated to 
ferritin synthesis as has found previously [22, 23, 36]. One possibility is that the aqueous fraction 
iron may bind to low molecular weight phytates, making it unavailable for uptake and ultimately 
ferritin synthesis [50].  
Some studies have achieved significant ferritin response by increasing the food sample 
quantity. Eagling et al (2014), increased the sample quantity from 0.5 g to 1 g and then to 3 g due 
to low ferritin response with lower amounts (< 3 g) of food [26]. For our experiment, we used 
only 2 g porridge, as  > 2 g resulted in thick sample that did not digest well.  However, their 
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unleavened bread flour samples contained very low iron concentrations (0.67-4.67 mg/100g) 
compared to our FBF samples (8.0-31.8 mg iron/100g).   
We anticipated that bioavailable iron may be higher in decorticated sorghum FBFs 
compared to corresponding whole FBFs because ANF localized in the outer layers of the grains 
would be lost during decortication [41]. In tannin-containing Seredo variety of sorghum, 
decortication by mechanical abrasion reduced the tannin content by 82% [51]. In another study 
with both tannin and non-tannin sorghum varieties, decortication reduced tannins by 79-92% 
[42]. However, ferritin concentrations after treatments with aqueous fractions from whole and 
decorticated sorghum-cowpea FBFs were not significantly different. On the other hand, we 
observed a slight decrease in ferritin response for all the decorticated sorghum-cowpea and 
sorghum-soy FBFs compared to their corresponding whole FBFs.  
With respect to vitamin A, data on the in-vitro bioavailability of vitamin A is very 
limited. While there are many studies on the carotenoid bioavailability [27, 37], there is so far 
only one study looked at the vitamin A bioavailability using the Caco-2 cell model [28]. Others 
studied vitamin A bioaccessibility using only in-vitro digestion [52] or bioavailability in clinical 
studies [53]. Vitamin A content in the current study ranged from 0.3 mg/100g in Cerelac to 1.67 
mg/100g in CSB+ (Table 3-5). Vitamin A content in Cerelac matched its labeled value, however 
CSB+ had 61% and CSB13 had 41% higher vitamin A levels than the fortified amount (Table 3-
2). The decorticated sorghum FBFs and degermed corn FBF contain lower vitamin A levels 
compared to their respective whole FBFs. Sorghum-cowpea and sorghum-soy FBFs contained 
10-58% higher vitamin A than the fortified levels of 0.488 mg/100g. It is not clear what caused 
these differences.   
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Vitamin A concentration in aqueous fraction was similar in all the samples. However, 
non-extruded CSB13 and CSB+ that contain highest vitamin A levels in dry FBF, showed lowest 
concentration in aqueous fractions compared to extruded FBFs and Cerelac. Cooking during 
porridge preparation and in-vitro digestion may have affected the vitamin A concentration [28] 
of non-extruded FBFs most than extruded ones. Another possibility for the lower aqueous 
fraction vitamin A levels in CSB+ may relate to its lower fat levels. CSB13 is a little harder to 
understand in this regard.   Also, sorghum-soy and corn-soy FBFs had lower vitamin A 
compared to sorghum-cowpea FBFs in aqueous fractions.  
Bioavailable vitamin A levels of FBFs measured by its concentration in Caco-2 cells after 
4 hour FBF treatment was not different between treatments. Red sorghum FBFs trended lower 
bioavailable vitamin A compared to white sorghum-cowpea FBFs. Even though the aqueous 
fraction vitamin A levels are lowest for CSB13 and CSB+, Caco-2 cell vitamin A concentrations 
were on par with white sorghum FBFs. This improvement might be caused by the cellular 
conversion of provitamin A carotenoids to vitamin A [54] for traditional corn-soy FBFs (Table 
3-7).  The similar increase in bioavailable vitamin A was not observed for extruded corn-soy 
FBF, may be related to only 48% corn compared to 70% corn in CSB13 and 79% corn in CSB+ 
(Table 3-1). 
It is difficult to compare in-vitro digestion/Caco-2 model iron bioavailability studies due 
to methodological differences. Some studies used a two chamber arrangement with dialysis 
membrane [55, 56, 22, 57], while others treated the Caco-2 cells directly with aqueous fraction 
[36, 23, 58]. Other studies have grown cells on inserts to study iron transport across the Caco-2 
monolayer [59]. Even though the Caco-2 cell density/well (50,000 cells/cm2) is similar in a 
majority of the studies, the day cells were used for bioavailability experiment varies. Some 
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studies used cells grown on 6 or 12 well plates 13 days post- seeding [26, 50], others used cells 
between a range of 14-16 days post-seeding [23]. In addition to the above mentioned differences, 
presentation of ferritin data greatly varied among studies. Some authors provided iron 
bioavailability as a percent of control or FeSO4 positive control [59, 60, 47, 58], whereas others 
provided actual ferritin values [26, 25, 24, 36].  
The major limitation of our study was that we did not observe a greater ferritin response 
with our samples. However multiple other studies also did not observe increases above baseline 
ferritin response [48, 49]. Some have found benefits from adding ascorbic acid externally, but 
the FBFs were fortified with ascorbic acid, which is probably not true of other foods assessed in 
this model [26, 61]. Also our study FBFs were fortified with ascorbic acid, which is probably not 
true of most of the other foods that were being used in other studies. Our study also lacks 
specific information about levels of antinutritional factors in FBFs such as phytates and tannins 
that have direct relevance to iron bioavailability. Study results should be extrapolated with 
caution, because a previous study that observed at or below baseline ferritin response in Caco-2 
cells, found significant improvements in iron status in animals when fed with the same samples 
[48]. However, in a rat study conducted with, by others in our laboratory, extruded sorghum-
cowpea, extruded sorghum-soy FBFs and CSB+ showed no significant difference in hemoglobin 
and liver iron levels (Delimont et al, manuscript in preparation), confirming our Caco-2 results of 
similar iron availability among FBFs. In line with our results, Pynaert et al (2006), found 
significantly higher soluble iron in processed compared to unprocessed complementary foods 
(CF). However the iron bioavailability of processed and unprocessed CF was similar due to a 
proportional decrease in Caco-2 cell iron uptake from processed CF [62]. In a previous clinical 
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study conducted with the same complementary foods, no difference in iron status was observed 
in infants fed processed and unprocessed CF [63]. 
 To the best of our knowledge, this is the first study looked at both bioavailable iron and 
vitamin A in FBFs. This research is important as major food aid receiving regions have high 
prevalence of anemia and vitamin A deficiency [64, 65]. In conclusion, our study results suggest 
that consumption of newly developed extruded sorghum-cowpea, sorghum-soy and corn-soy 
FBFs will result in iron and vitamin A status comparable to traditional non-extruded CSB13 and 
CSB+ FBFs. As the antinutrient phytate content influenced iron bioavailability more than the 
iron content in the food [26], future studies should give emphasis to analyzing the antinutrient 
levels in iron bioavailability studies. Also these novel sorghum-FBFs should be tested in animal 
and clinical trials to confirm the current study results. 
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Table 3-1 Composition of Cerelac, extruded FBFs and non-extruded FBFs. 
†  For extruded SSB (full-fat soy) & extruded CSB (full-fat soy), WPC80 was increased from 9.5% to 13% and vegetable oil was 
decreased from 9% to 5.5%. For Cerelac, ingredient % was not available, ingredients were listed in the order on the label.  
 Extruded FBFs  Traditional FBFs Cerelac 
Ingredient (%) SCB SSB† CSB† Ingredient (%) CSB13 CSB+ Ingredient  
Sorghum Flour  24.7 47.6  - Cornmeal 69.5  - Wheat Flour 
Cowpea Flour 38.6  -  - Soy Flour, Defatted 21.9  - Fat Free Milk 
Corn Flour  - - 48.1 Soybean Oil, Refined 5.5  - Sugar 
Soy Flour  - 15.7 15.2 Minerals 3.0  - Milk Fat 
Sugar 15.0 15.0 15.0 Vitamin Antioxidant Premix 0.1  - Corn Oil 
Whey Protein Concentrate  9.5 9.5 9.5 Corn (White or Yellow)  - 78.5 Palm Oil 
Vegetable Oil  9.0 9.0 9.0 Whole Soybeans  - 20.0 Calcium Carbonate 
Vitamin & Mineral Premix 3.2 3.2 3.1 Vitamin/Mineral  - 0.2 Sodium Phosphate 
        Tri-Calcium Phosphate  - 1.2 Bifidus Cultures 
        Potassium Chloride  - 0.2 Vitamin & Mineral Mix  
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Table 3-2 Macronutrient and micronutrient formulation of FBFs and Cerelac. 
Nutrient in 100g Unit 
SCB/SSB 
/CSB 
CSB 13 CSB+ Cerelac 
Energy kcal  380 386 380 400 
Protein g  17 16 14 13 
Fat G 8 9 6 10 
Vitamin A Mg 0.488 0.819 1.04 0.344 
Thiamin (B1) Mg 0.652 0.61 0.20 0.28 
Riboflavin (B2) Mg 0.933 0.481 1.40 0.80 
Niacin (B3) Mg 9.07 6.29 8.0 2.40 
Pantothenic Acid (B5) Mg 3.646 3.285 1.60 1.33 
Vitamin B6 Mg 0.752 0.532 1.0 0.280 
Folic Acid (B9) Mg 0.087 0.247 0.11 0.053 
Vitamin B12 Mg 0.0015 0.001 0.002 0.001 
Vitamin D Mg 0.029  0.005 0.011 0.004 
Vitamin E Mg 13.22  0.98 8.3 3.0 
Vitamin K Mg 0.033 0.001 0.03 0.03 
Vitamin C Mg 40.0 40.2 90 16.0 
Calcium Mg 279.08 650 452 426.67 
Total Iron (Fe) Mg 13.0 10.6 6.5 5.33 
Fe (FeSO4) Mg 11.0 0.0 4.0 0.0 
Fe (NAFeEDTA) Mg 2.0 0.0 2.5 0.0 
Fe (Ferrous fumarate) Mg 0.0 10.6 4.0 5.33 
Iodine Mg 0.23 0.0 0.04 0.03 
Phosphorus Mg 290.97 522.0 290.0 426.67 
Potassium mg 163.19 563.0 140.0 NA 
Zinc mg 5.5 5.94 5.0 2.13 
      
For Cerelac, macronutrient and micronutrient values were calculated based on the label 
information for % Daily Value (% DV), and daily values for children under 4 years provided by 
US Food and Drug Administration, Guidance for Industry: A Food Labeling Guide (15. 
Appendix G: Daily Values for Infants, Children Less Than 4 Years of Age, and Pregnant and 
Lactating Women). NA-values not available.  
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Table 3-3 Iron concentrations in dry FBFs, Cerelac and aqueous fractions (mean ± SEM). 
Cereal Cereal type Legume 
Dry FBF 
(mg/100g) 
Aqueous 
fraction* 
(µg/10ml) 
Sorghum-Cowpea blends 
White Sorghum 1 Whole Cowpea 19.5  9.3 ± 0.2a 
White Sorghum 1 Decorticated Cowpea 18.6  10.3 ± 0.6a 
White Sorghum 1 Decorticated, commercial Cowpea 15.1  6.6 ± 1.1ac 
White Sorghum 2 Whole Cowpea 19.5  6.8 ± 1.7ac 
White Sorghum 2 Decorticated Cowpea 15.9  8.2 ± 0.3ac 
Red Sorghum Whole Cowpea 19.1  8.0 ± 0.8ac 
Red Sorghum Decorticated Cowpea 15.3  6.2 ± 1.8ac 
Sorghum-Soy blends 
White Sorghum 1 Whole Low Fat soy 23.4  9.5 ± 0.6a 
White Sorghum 1 Decorticated Medium Fat Soy 15.6  8.5 ± 0.5ac 
White Sorghum 1 Whole Full Fat soy 20.7  9.2 ± 0.3a 
Corn-Soy blends 
Corn Degermed, coarse, commercial Medium Fat Soy 15.6  7.5 ± 0.9ac 
CSB13 Cornmeal Defatted Soy flour 31.8  1.7 ± 0.3b 
CSB+ Whole Corn Whole Soy   8.0  1.4 ± 0.3b 
Cerelac Wheat 11.4  4.2 ± 0.1bc 
*Aqueous fractions (n=2) from two different in-vitro digestion experiments were included for 
statistical analysis. Within a column, means without a common superscript are significantly different 
(p<0.05). 
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Table 3-4 Caco-2 cell ferritin levels following aqueous fraction treatment (n=2, mean ± SEM). 
Cereal Cereal type Legume 
Ferritin 
(ng/mg) 
Sorghum-Cowpea blends 
White Sorghum 1 Whole Cowpea 6.21 ± 1.68 a 
White Sorghum 1 Decorticated Cowpea 4.66 ± 0.05 a  
White Sorghum 1 Decorticated, commercial Cowpea 4.74 ± 0.05 a 
White Sorghum 2 Whole Cowpea 6.52 ± 1.83 a 
White Sorghum 2 Decorticated Cowpea 5.47 ± 2.05 a 
Red Sorghum Whole Cowpea 5.24 ± 1.35 a 
Red Sorghum Decorticated Cowpea 4.13 ± 1.01 a 
Sorghum-Soy blends 
White Sorghum 1 Whole Low Fat soy 6.51 ± 2.17 a 
White Sorghum 1 Decorticated Medium Fat Soy 5.97 ± 3.06 a 
White Sorghum 1 Whole Full Fat soy 4.10 ± 1.22 a 
Corn-Soy blends 
Corn Degermed, coarse, commercial Medium Fat Soy 6.78 ± 0.64 ab 
CSB13 Cornmeal Defatted Soy flour 4.72 ± 0.73 a 
CSB+ Whole Corn Whole Soy 7.39 ± 1.76 ab 
Controls 
Cerelac Wheat  4.89± 0.53 a 
Basal salt solution (negative control)  4.75 ± 1.04 a 
FeSO4 (0.1 µg Fe/well) (positive control)  15.87 ± 5.73
ab 
FeSO4 (0.2 µg Fe/well) (positive control)  29.65 ± 3.26
 b 
Within a column, means without a common superscript are significantly different (p<0.05). 
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Table 3-5 Vitamin A content in dry FBFs, Cerelac and aqueous fractions (mean ± SEM).  
Cereal Cereal type Legume Dry FBF 
(mg/100g) 
Aqueous 
fraction 
(ng/ml) 
Sorghum-Cowpea blends 
White Sorghum 1 Whole Cowpea 0.75 60.8 ± 10.0 
White Sorghum 1 Decorticated Cowpea 0.70 69.6 ± 15.9 
White Sorghum 1 Decorticated, commercial Cowpea 0.54 50.8 ± 5.0 
White Sorghum 2 Whole Cowpea 0.71 52.7 ± 7.7 
White Sorghum 2 Decorticated Cowpea 0.56 80.1 ± 15.4 
Red Sorghum Whole Cowpea 0.76 77.6 ± 2.8 
Red Sorghum Decorticated Cowpea 0.54 67.4 ± 27.7 
Sorghum-Soy blends 
White Sorghum 1 Whole Low Fat soy 0.72 48.0 ± 4.0 
White Sorghum 1 Decorticated Medium Fat Soy 0.59 44.8 ± 10.9 
White Sorghum 1 Whole Full Fat soy 0.75 49.1 ± 0.8 
Corn-Soy blends 
Corn Degermed, coarse, commercial Medium Fat Soy 0.56 45.9 ± 12.8 
CSB13 Cornmeal Defatted Soy flour 1.16 33.0 ± 0.4 
CSB Plus Whole Corn Whole Soy 1.67 41.5 ± 28.2 
Cerelac 
Cerelac Wheat   0.30 55.6 ± 25.6 
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Table 3-6 Caco-2 cell vitamin A levels following aqueous fraction treatment (n=2, mean ± 
SEM). 
Cereal Cereal type Legume Vitamin A 
(µg/g cells) 
Sorghum-Cowpea blends 
White Sorghum 1 Whole Cowpea 2.59 ± 0.35 
White Sorghum 1 Decorticated Cowpea 2.52 ± 0.13 
White Sorghum 1 Decorticated, commercial Cowpea 2.34 ± 0.15 
White Sorghum 2 Whole Cowpea 2.23 ± 0.12 
White Sorghum 2 Decorticated Cowpea 2.29 ± 0.15 
Red Sorghum Whole Cowpea 1.89 ± 0.52 
Red Sorghum Decorticated Cowpea 1.99 ± 0.14 
Sorghum-Soy blends 
White Sorghum 1 Whole Low Fat Soy 1.96 ± 0.11 
White Sorghum 1 Decorticated Medium Fat Soy 2.13 ± 0.01 
White Sorghum 1 Whole Full Fat Soy 2.09 ± 0.69 
Corn-Soy blends 
Corn Degermed, coarse, commercial Medium Fat Soy 1.96 ± 0.01 
CSB13† Cornmeal Defatted Soy Flour 2.03 
CSB Plus† Whole Corn Whole Soy 2.43 
Controls 
Cerelac Wheat   2.24 ± 0.10 
Basal salt solution     2.09 ± 0.21  
Control cells†     1.82 
†  For CSB13, CSB+ and control cells single analysis data was included due to sample loss. 
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Chapter 4 - Fatty Acid and Phytosterol Content of Commercial 
Saw Palmetto Supplements 
 
 Abstract 
Saw palmetto supplements are one of the most commonly consumed supplements by men 
with prostate cancer and/or benign prostatic hyperplasia (BPH). Some studies have found significant 
improvements in BPH and lower urinary tract symptoms (LUTS) with saw palmetto 
supplementation, whereas others found no benefits. The variation in the efficacy in these trials may 
be a result of differences in the putative active components, fatty acids and phytosterols, of the saw 
palmetto supplements. To this end, we quantified the major fatty acids (laurate, myristate, palmitate, 
stearate, oleate, linoleate) and phytosterols (campesterol, stigmasterol, β-sitosterol) in 20 
commercially available saw palmetto supplements using GC-FID and GC-MS, respectively. Samples 
were classified into liquids, powders, dried berries, and tinctures. Liquid saw palmetto supplements 
contained significantly higher (p<0.05) concentrations of total fatty acids (908.5 mg/g), individual 
fatty acids, total phytosterols (2.04 mg/g), and individual phytosterols, than the other supplement 
categories. Powders contained significantly higher (p<0.05) concentrations of total fatty acids than 
tinctures, which contain negligible amounts of fatty acids (46.3 mg/g) and phytosterols (0.10 mg/g). 
Our findings suggest that liquid saw palmetto supplements may be the best choice for individuals 
who want to take a saw palmetto supplement with the highest concentrations of both fatty acids 
and phytosterols. 
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 Introduction 
Saw palmetto (Serenoa repens) herbal supplements are commonly used by men to 
combat benign prostatic hyperplasia (BPH), a nonmalignant enlargement of the prostate. In 
addition to BPH, these supplements are commonly consumed by men diagnosed with prostate 
cancer. In 2007, 5.1% (~1.7 million people) of Americans 18 years of age or older reported using 
saw palmetto in the past 30 days [1]. In 2011, over $18 million in saw palmetto was sold in the 
United States, ranking third among herbal dietary supplements [2]. A systematic literature review 
of 11 studies identified saw palmetto supplements as one of five commonly used complementary 
or alternative medicine modalities by men with prostate cancer; use was 1.9–24.9% [3]. Another 
study found that 13.8% of unaffected men whose brothers had been diagnosed with prostate 
cancer had taken saw palmetto at some point in their lives [4]. 
Saw palmetto’s putative mechanism of action is inhibition of 5α-reductase, the enzyme 
that converts testosterone into the more potent androgen dihydrotestoterone [5-10]. Studies that 
have found saw palmetto administration or treatment reduced androgen action support this belief 
[11-15]; however, not all studies have found that saw palmetto inhibits 5α-reductase or has anti-
androgen action [16-18]. The believed bioactive components of saw palmetto are fatty acids and 
phytosterols. Saw palmetto extracts predominantly consist of fatty acids (~90%) and are unique 
compared with other extracts and vegetable and nut oils [19] in that they are a rich source of the 
saturated, medium-chain fatty acids laurate (12:0) and myristate (14:0) [20].  
Several studies suggest that the fatty acids in saw palmetto extracts are responsible for its 
ability to inhibit 5α-reductase [21-26], but which fatty acid(s) is/are responsible for the inhibition 
varies. Some research suggests that saw palmetto phytosterols, (β-sitosterol, campesterol, 
stigmasterol) inhibit 5α-reductase, prostate cancer cell/tumor growth, and/or BPH symptoms [27-
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31]; however, these phytosterols are not unique to saw palmetto extracts [32]. Nevertheless, a 
combination of fatty acids, phytosterols, and other bioactive components may be responsible for 
beneficial effects reported from saw palmetto supplements.  
Saw palmetto extract decreased testosterone-induced prostate hyperplasia [15] in rats and 
prostate cancer progression in TRAMP mice [14]. A number of studies have found that saw 
palmetto supplements improve lower urinary tract symptoms (LUTS) in men suffering from 
BPH. The two largest, highest-quality BPH clinical trials [33, 34], however, failed to find a 
benefit of supplementation, leading a systematic literature review to conclude that saw palmetto 
supplementation provides no benefit [35]. 
Although methodological issues or distinctions may be responsible for these conflicting 
findings, it is also possible that differences in the nutrient profiles of the saw palmetto 
supplements used in the studies influenced the results. In support of this possibility, different saw 
palmetto supplements exhibited varied effectiveness in inhibiting 5α-reductase activity and 
prostate cancer cell proliferation [36, 37]. In addition, Wolsko et al. found that only 6/26 (26%) 
of published saw palmetto randomized-controlled trials reported performing quantitative analysis 
on the extract used [38]. This is important because the fatty acid content of saw palmetto 
supplements has been found to be -97% to +140% of stated dosages [39], and a separate study 
found that the supplements mean free fatty acid percentages ranged from 40.7% to 80.7% [40].  
Others have also measured fatty acid [15, 20, 41-43] or phytosterol content [42, 44-45] 
of saw palmetto, but despite the reported differences in saw palmetto supplement contents, to the 
best of our knowledge, no one has characterized both the fatty acid and phytosterol contents of 
commercially available supplements or compared different supplement categories. Thus, we set 
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out to characterize these saw palmetto supplement components, hypothesizing that we would 
find large differences in their quantities and composition. 
 Materials and Methods 
 Sample procurement 
Twenty commercially available saw palmetto supplements were procured from online 
and local sources. Standard reference material (SRM) 3251, a Serenoa repens extract, was 
purchased from the National Institute of Standards and Technology (NIST; Gaithersurg, MD) to 
ensure the accuracy of the fatty acid and phytosterol analysis [20]. Supplements were classified 
into the following categories based on their physical properties: 1) liquids, 2) powders, 3) dried 
berries, and 4) tinctures (Table 1). 
 Sample preparation 
Representative samples from each category were prepared as follows. For liquids, 4–5 gel 
capsules were emptied into a microcentrifuge tube and gently vortexed. For powders, 4–5 
powder capsules were emptied into a weigh boat and the contents were mixed thoroughly with a 
spatula to break up any lumps; tablets were ground to smooth powder using a mortar and pestle. 
Dried berries were ground using a coffee grinder until they reached a coarse powder texture. 
Tincture bottles were vortexed before taking a sample. SRM ampoules were vortexed and the 
contents were transferred to microcentifuge tubes. Samples, and SRM, were extracted and 
analyzed in duplicate. Care was taken to select the duplicates from the same lot number. All 
materials were from Fisher Scientific (Pittsburgh, PA) unless noted. 
  Fatty acid extraction and transesterification 
Fatty acids were prepared for analysis using the one-step extraction-transesterification 
method [46]. Approximately 40 mg of SRM, 40 mg of liquid supplements, 150 mg of powder 
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supplements, 150 mg of dried berry powder, or 250 mg of tinctures were placed into 15-ml tubes 
with Teflon-lined screw caps. These amounts were selected because they were estimated to 
contain ~10–50 mg of total fatty acids based on label information. Two milliliters of benzene 
containing 2 mg of the internal standard methyl tridecanoate (Sigma-Aldrich, St. Louis, MO) and 
3 ml of freshly prepared methanolic-HCl were added. The tubes were capped, vortexed, and 
incubated at 70oC for 2 h in a water bath. After allowing them to cool to room temperature, 5 ml 
of 6% potassium carbonate and 2 ml of benzene were added, and the tubes were vortexed and 
centrifuged at 500x g for 5 min. The supernatant was carefully transferred to vials for analysis. 
  Fatty acid methyl esters (FAMEs) gas chromatography-flame ionization detector 
(GC-FID) analysis  
Sample extracts were analyzed for fatty acid methyl esters using a Hewlett-Packard 
model 5890 GC (Hewlett-Packard, Palo Alto, CA, USA) with a SP-2560 capillary column (100m 
x 0.25mm x df 0.2μm, Supelco, Inc., Bellefonte, PA, USA). Injection port and detector 
temperatures were maintained at 250oC. Helium was used as the carrier gas at a flow rate of 1 
ml/min. One microliter of sample was injected at a split ratio of 100:1. A temperature gradient 
was used with an initial oven temperature of 140°C that increased to 200°C at 2°C/min, then to 
245°C at 4°C/min, and the sample held at this temperature for 17 min. The total run time was 66 
min. Fatty acid methyl esters (FAMEs) were identified by their retention times using the FAME 
standard mix (Supelco, Bellefonte, PA, USA) and quantified using Agilent ChemStation 
software [47]. Thirty-seven fatty acids were analyzed and quantified and contributed to the total 
fatty acid results reported, but only the six major fatty acids, laurate (C12:0), myristate (C14:0), 
palmitate (C16:0), stearate (C18:0), oleate (C18:1), and linoleate (C18:2), are reported 
100 
individually.  The mean percent coefficient of variance between duplicates for total fatty acids 
was 0.8%. 
 Phytosterol extraction 
Phytosterols were extracted using a modficiation of a method described previously [48]. 
Approximately 100 mg of SRM, liquid, powder, and dried berry supplements and 1000 mg of 
tincture supplements were weighed into separate 250-ml Erlenmeyer flasks. Forty milliliters of 
0.3M potassium hydroxide in methanol and 10 µl (1 mg/ml chloroform) of cholestanol (Steraloids, 
Inc. Newport, RI, USA) were added to each flask. The extracts were distilled at 80oC using a 
condenser for 1 h with continuous stirring. After cooling the flasks to room temperature, 40 ml of 
double-distilled water was added. Twenty milliliters of hexane was then added, and the contents 
were transferred to a separatory funnel. The separatory funnel was carefully inverted, gently 
rotated, then allowed to stand for 5–10 min. The bottom white turbid aqueous layer was discarded. 
The contents of the separatory funnel were then extracted by adding 20 ml of hexane twice. The 
clear hexane layers were collected and filtered through a glass funnel containing glass wool and 
sodium sulfate. Filtered hexane extracts were concentrated using a Brinkmann Buchi Rotavapor 
R110 (Buchi, Switzerland) at 50oC, transferred to test tubes, then evaporated to dryness under 
nitrogen. The dried contents were redissolved in 1 ml of chloroform and stored at -80oC for 
derivatization. 
 Phytosterol derivatization 
Phytosterols were derivitaized and analyzed by gas chromatography-mass spectrometry 
as described previously with modifications [49]. Two hundred microliters of extracted sample 
was used for derivatization. A smaller volume was used for samples that contained high levels of 
phytosterols. Samples were placed in 1.5-ml screw-cap GC vials (Agilent, Santa Clara, CA, 
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USA), dried completely under nitrogen, and redissolved in 70 µL pyridine (99.5% extra dry with 
AcroSeal, Acros Organics, Geel, Belgium) for derivatization. The samples in pyridine were 
derivatized by adding 30 µL of N-trimethylsilyl-N-methyltrifluoroacetamide with 1% 
trimethylchlorosilane (MSTA +1% TMCS Thermo Scientific, Bellefonte, PA, USA) and 
incubated at 50°C for 60 min on a hot plate. Derivatized samples were completely dried down 
under nitrogen, redissolved in 100 µL of chloroform, and analyzed within 24 h of derivatization. 
  Phytosterol gas chromatography-mass spectrometry (GC-MS) 
GC-MS was performed on an Agilent 6890N GC coupled to an Agilent 5975N quadruple 
mass selective detector. The GC was fitted with a DB-5MS capillary column (60m x 0.25mm, x 
df 0.25 µm, Agilent Technologies, Santa Clara, CA, USA) with a 5% phenyl methyl siloxane 
stationary phase. Helium was used as the carrier gas at a column flow rate of 1 mL/min. The 
front inlet was operating at a pressure of 22.33 psi and 280°C. An Agilent 7683 autosampler was 
used to inject 1 µL of the sample in the splitless mode. The GC temperature program was: initial 
temperature of 80°C, increased 25°C/min to 300°C, then increased 3°C/min to a final 
temperature of 325°C, where it was held for 7 min. The total run time was 24.5 min. The mass 
spectrometer was operated in the electron impact (EI) mode at 70 eV ionization energy. The MS 
quad temperature was at 150°C, and the MS source temperature was at 230°C. The data were 
processed with Agilent Chemstation. The three major phytosterols campesterol, stigmasterol, β-
sitosterol, were quantified and summed to calculate total phytosterol content. The mean percent 
coefficient of variance between replicates for total phytosterol was 10.8%.  
  Statistical analysis 
Data were analyzed using SAS 9.3 (SAS Institute Inc., Cary, NC, USA), with p<0.05 
considered significant. Natural logs were used to transform data that did not meet the 
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assumptions of normality and/or homogeneity of variance. Differences in individual fatty acid 
and phytosterol quantities and percentages, total fatty acid and phytosterol quantities, and 
percentages among the four supplement categories were analyzed using one-way ANOVA with 
Tukey’s test. The variation between duplicates was assessed by dividing the standard deviation 
with duplicate mean and multiplying with 100 to calculate the mean % coefficient of variation. 
 
 Results  
 Fatty acid quantities and percentages between supplement categories 
Fatty acid quantities and percentages of the SRM, liquid, powder, dried berry, and 
tincture saw palmetto supplements are shown in Tables 2 and 3. Nature’s Answer was not 
included in the tincture means and was excluded from statistical analysis due to its negligible 
fatty acid content (0.1 mg/g). Oleate and laurate were the predominant fatty acids across the 
different supplement categories. Liquid supplements contained significantly higher quantities of 
total (908.5 mg/g) and individual fatty acids than powder, dried berry, and tincture supplements. 
Liquid supplements contained significantly higher percentages of oleate and total fatty acids and 
significantly lower percentages of laurate and myristate than the other supplement categories. 
The total fatty acid content of powder supplements (179.6 mg/g) was similar to dried berry 
(126.4 mg/g) but significantly higher than tincture supplements (46.3 mg/g). Powder 
supplements contained significantly higher quantities of palmitate and stearate than dried berries 
and tinctures and significantly higher quantities of linoleate and total fatty acids than dried 
berries. Powder supplements contained significantly higher palmitate and stearate percentages 
than the other supplement categories, and tinctures contained significantly higher percentages of 
laurate than liquid and powder supplements. 
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  Fatty acid quantities and percentages within supplement categories 
Within supplement categories, fatty acid quantities and percentages across the three dried 
berry supplements were fairly consistent (Tables 2 and 3). Tinctures, on the other hand, varied 
widely, with total fatty acids ranging from 0.1–97.3 mg/g. There was less variability in total fatty 
acids in liquids (710.3–941.3 mg/g) and powders (68.6–327.3 mg/g); however, there were some 
notable trends. Among liquid supplements, Doctor’s Best and Saw Palmetto Harvesting 
Company contained higher laurate and myristate and lower oleate quantities. Jarrow Formulas 
contained much higher quantities of linoleate than the other liquid supplements. Among powder 
supplements, Biochem contained lower quantities of laurate and myristate levels but higher 
quantities of stearate and oleate. 
  Phytosterol quantities and percentages within supplement categories 
Liquid and powder supplements had similar quantities of individual and total 
phytosterols, with the exception of Jarrow Formulas and Biochem, which contained much higher 
phytosterol quantities (Tables 4 and 5). Dried berry supplements had similar quantities and 
percentages of individual and total phytosterols. All tincture supplements contained low 
phytosterols quantities.   
 Difference between stated and measured total fatty acid content  
Stated total fatty acid content from supplement labels was only available for liquid 
supplements. These stated quantities are compared to measured content in Table 6. Measured 
total fatty acid content in five out of six liquid supplements was greater than or equal to the 
quantities stated on their labels. It is worth noting that one supplement whose measured content 
(833 mg/g) was below its stated amount, Jarrow Formulas, was only 7% lower than its stated 
content (850-950 mg/g). 
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 Discussion  
We found great variability in total and individual fatty acid and phytosterol quantities and 
percentages in 20 commercial saw palmetto supplements. There was also a great deal of 
variability in the total and individual fatty acid and phytosterol quantities and percentages 
between the four different saw palmetto supplement categories. We believe we are the first to 
collect and analyze samples from these different supplement categories. Overall, we found that 
liquid supplements contained the highest fatty acid and phytosterol quantities, followed by 
powder, dried berry, and tincture supplements. 
Fatty acid and phytosterol contents have been reported previously for SRM 3251 [20]. 
Because total fatty acid quantities were not reported, we multiplied the reported free fatty acid 
composition by the triglyceride to free fatty acid ratio. Our measured total fatty acid and total 
phytosterol contents (908.5 mg/g, 2.0 mg/g) are comparable with the calculated SRM 3251 values 
(983.6 mg/g, 2.4 mg/g). These results support that our extraction and analysis procedures were 
accurate in measuring these components. The total fatty acid percentages of liquid samples (83.3–
94.1%) are consistent with the values reported for hexane (98.7–99.7%) [41], supercritical CO2 
(96.1–97.4%) [42], CO2 (92.2%) [43], ethanol (88,7%) [43] and lipid (92.5%) [15] saw palmetto 
extracts. The total fatty acid percentages are also consistent with the sum of the free fatty acids, 
esters, and glycerides (87.0–95.3%) in 14 European saw palmetto extracts [40]. However, the 
total fatty acid percentages are higher than those reported for a saw palmetto ethanol extract 
(68.7%) [43]. 
Dried berry supplements contained 11.6–13.4% fatty acids, which is similar to the levels 
reported in SRM 3250 (~15.8%), a saw palmetto berry, when calculated as described above [20]. 
Permixon, one of the powder supplements, has been analyzed previously and reported to contain 
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91.4% free fatty acids, esters, and glycerides [40]. This was far higher than the 32.7% fatty acid 
content that we measured. Our method may not extract fatty acids efficiently from powder 
samples and could be underestimating the fatty acid content. To the best of our knowledge, we 
are the first to measure tincture saw palmetto supplements. The levels of the major phytosterols 
(campesterol, stigamasterol, and β-sitosterol) in the saw palmetto supplements is consistent with 
quantities found in a variety of previously analyzed saw palmetto supplements [44] and is similar 
to the β-sitosterol content in a supercritical CO2 saw palmetto extract [42]. 
Ingredients added to saw palmetto supplements (Table 1) help explain the differences we 
found in fatty acid and phytosterol quantities and percentages. Most liquid, and a few powder, 
supplements contain added ingredients. For instance, among liquid supplements, only Doctor’s 
Best and Saw Palmetto Harvesting Company had no or a limited number of extra ingredients 
added to them. This probably explains why they have much higher laurate and myristate 
quantities. Jarrow Formulas, on the other hand, has a pumpkin seed oil base that is enriched in 
phytosterols, which explains its high linoleate and phytosterol quantities. The remaining four 
liquid supplements contained either olive oil or extra virgin olive oil (GNC Herbal Plus, Spring 
Valley Natural Foods, Now Foods, Solaray), which explains their higher oleate percentages 
compared to other liquid supplements. The powder supplements Nature’s Way and Biochem 
contain magnesium stearate, which explains their high quantities of stearate. Biochem also 
contains pygeum root extract, which is probably the reason why the supplement contains very 
high quantities of phytosterols [50]. 
Industrial preparative extraction method may also help explain the differences in fatty 
acid and phytosterol quantities in the supplements. Saw palmetto supplements are usually 
extracted using solvents like hexane, ethyl alcohol, or supercritical CO2. All the tinctures were 
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alcohol-extracted, but among liquid and powder supplements, only Doctor’s Best and Jarrow 
Formulas, which were extracted using supercritical CO2, stated how they were extracted. Thus, 
the unknowne methods used to produce the supplements prevent us from understanding how 
extraction affects supplement fatty acid and phytosterol content. Other factors that might also 
contribute to the variation in the seen are batch and plant growing conditions. 
We found that 83% of the liquid supplements contained greater than or equal to their 
stated fatty acid content. This is higher than the 33% of the measured saw palmetto supplements 
analyzed in a previous study [39]. Supplement companies that state their fatty acid content may 
be employing better manufacturing procedures and analyzing their products to ensure they 
contain the stated values.  
 Conclusions  
We believe we are the first to characterize both fatty acid and phytosterol content of 
commercial saw palmetto supplements. We plan to determine the anti-androgen action of saw 
palmetto supplements with different nutrient profiles hoping that the understanding gained will 
explain the varied response to saw palmetto supplements seen in previous studies.  
  Implications 
Our findings suggest that liquid saw palmetto supplements are the best choice for 
individuals who want to take a saw palmetto supplement because they contain higher 
concentrations of both fatty acids and phytosterols than other types of saw palmetto supplements. 
However, further research is needed to determine whether these supplements are indeed more 
efficacious. 
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Table 4-1  Saw palmetto supplements’ names, manufacturing locations, and other added ingredients. 
Saw palmetto supplement Other label ingredients Lot Number 
Liquids  
Doctor's Best (San Clemente, CA) Gelatin, glycerin, water 9I1215 
GNC Herbal Plus (Pittsburgh, PA) 
Olive oil, gelatin, glycerin, caramel color, titanium 
dioxide  
NI 
Spring Valley Natural Foods (Springfield, MO) Olive oil, gelatin, glycerin, water 36994690904 
Now Foods (Bloomingdale, IL) Extra virgin olive oil, gelatin, glycerin 11676001159 
Solaray (Park City, UT) Extra virgin olive oil, gelatin, glycerin 132812 
Saw Palmetto Harvesting Company (Lengby, MN) NI NI 
Jarrow Formulas (Los Angeles, CA) Pumpkin seed oil, vitamin E, gelatin, glycerin, water  43044J9 
Powders  
Permixon (Pierre Fabre Medicament, Boulogne Cedex, 
France) 
NI 
G06167 
Biochem (Country Life, Hauppauge, NY) 
Pygeum extract, magnesium stearate, calcium 
silicate, magnesium silicate, silica, cellulose 
09G802C 
Natures' Way Products, Inc. (Springville, UT) Magnesium stearate, gelatin, glycerin 585612 
Solaray (Park City, UT) Vegetable cellulose capsule 140401 
GNC Saw Palmetto  Formula (Pittsburgh, PA) 
Pumpkin seed meal powder, pygeum bark powder, 
lycopene, zinc, cellulose, dicalcium phosphate, 
povidone  
5795KJ3613 
Dried Berries  
Mountain Rose Herbs (Dried Berries, Eugene, OR) None 9498 
Mountain Rose Herbs (Powdered Berries, Eugene, OR) None 9646 
More than alive (Powdered Berries, Lobelville, TN) None NI 
Tinctures  
Oregon's Wild Harvest (Sandy, OR) Organic alcohol, water SB12159E01 
GAIA Herbs, Inc. (Brevard, NC) Grain alcohol  6212054600 
LA Naturals (Michigan City, IN) Grain alcohol 70–80%, deionized water 7R44ALL 
Teeter Creek Herbs (Ava, MO) Grain alcohol 40–50%, distilled water NI 
Nature's Answer (Hauppauge, NY) 
Vegetable glycerin, purified United States 
Pharmacopeia (USP) water 
092469 
NI–no information on the label  
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 Table 4-2 Fatty acid quantities (mg/g) and composition (% of total fatty acids) in SRM, liquid, and powder saw palmetto supplements. 
* % of dry mass (weight/weight), different letters indicate significant differences (p<0.05) between the four categories. Samples, and SRM from the same 
lot, were extracted and analyzed in duplicate. 
  
  
 Supplement 
Laurate 
 (C12:0) 
Myristate 
(C14:0) 
Palmitate 
(C16:0) 
Stearate 
(C18:0) 
Oleate   
(C18:1) 
Linoleate 
(C18:2) 
Total fatty 
acid 
  mg/g % mg/g % mg/g % mg/g % mg/g % mg/g % mg/g %* 
Liquid extracts (n = 7) 
Doctor's Best 276.6 29.4 105.4 11.2 86.9 9.2 17.5 1.9 313.9 33.4 43.6 4.6 941.3 94.1 
GNC Herbal Plus 82.9 8.9 33.8 3.6 94.0 10.1 25.4 2.7 582.3 62.4 59.1 6.3 933.8 93.4 
Spring Valley Natural Foods 170.3 18.5 67.6 7.3 85.8 9.3 24.1 2.6 448.5 48.6 53.9 5.8 923.4 92.3 
Now Foods 141.6 15.5 51.6 5.7 107.0 11.7 21.1 2.3 438.1 47.9 81.0 8.9 914.7 91.5 
Solaray 141.9 15.6 57.1 6.3 90.9 10.0 21.2 2.3 476.0 52.1 55.6 6.1 913.0 91.3 
Saw Palmetto Harvesting Company 254.9 28.3 98.5 11.0 84.4 9.4 16.2 1.8 312.5 34.7 34.1 3.8 900.0 90.0 
Jarrow Formulas 127.2 15.3 47.5 5.7 93.1 11.2 32.5 3.9 230.2 27.6 248.2 29.8 833.4 83.3 
Mean 170.8a 18.8a 65.9a 7.2a 91.7a 10.1a 22.6a 2.5a 400.2a 43.8a 82.2a 9.3a 908.5a 90.9a 
SEM 18.0 1.9 6.9 0.7 2.0 0.2 1.4 0.2 30.9 3.2 19.2 2.4 9.6 1.0 
Powders (n = 5) 
Permixon 96.7 29.5 38.5 11.8 30.5 9.3 5.6 1.7 111.7 34.1 11.5 3.5 327.3 32.7 
Biochem 40.7 17.1 16.2 6.8 58.2 24.4 47.0 19.7 36.4 15.3 19.1 8.0 238.3 23.8 
Natures' Way 38.0 26.5 14.3 10.0 18.2 12.7 14.4 10.0 40.1 27.9 6.5 4.5 143.6 14.4 
Solaray 40.5 33.7 14.8 12.3 11.9 9.9 2.5 2.1 34.2 28.5 6.1 5.1 120.1 12.0 
GNC Saw Palmetto Formula 14.6 21.3 5.6 8.2 15.2 22.1 9.6 13.9 14.6 21.2 4.6 6.7 68.6 6.9 
Mean 46.1b 25.6b 17.9b 9.8b 26.8b 15.7b 15.8b 9.5b 47.4b 25.4b 9.6b 5.6a 179.6b 18.0b 
SEM 9.0 2.0 3.7 0.7 5.7 2.1 5.4 2.3 11.1 2.2 1.8 0.5 30.7 3.1 
Standard reference material 
SRM 3251 259.9 26.3  10.6 10.6 86.6 8.5  16.9 1.7  331.1  34.6 50.2  6.0 983.6  98.4 
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  Table 4-3  Fatty acid quantities (mg/g) and composition (% of total fatty acids) in dried berry and tincture saw palmetto supplements. 
 
* % of dry mass (weight/weight), ** Nature’s Answer was excluded from statistical analysis due to its negligible fatty acid content compared with other 
products. Different letters indicate significant differences (p<0.05) between the four categories Samples, and SRM from the same lot, were extracted and 
analyzed in duplicate. 
  
  
 Supplement 
Laurate 
 (C12:0) 
Myristate 
(C14:0) 
Palmitate 
(C16:0) 
Stearate 
(C18:0) 
Oleate   
(C18:1) 
Linoleate 
(C18:2) 
Total fatty  
acid 
  mg/g % mg/g % mg/g % mg/g % mg/g % mg/g % mg/g %* 
Dried berries (n =3) 
Mountain Rose Herbs (dried berries) 41.7 31.1 15.1 11.3 12.4 9.3 2.6 1.9 41.2 30.8 6.6 4.9 134.0 13.4 
Mountain Rose Herbs (powdered berries) 37.1 28.6 15.6 12.0 12.6 9.7 2.1 1.7 43.9 33.9 4.8 3.7 129.7 13.0 
More than Alive (powdered  berries) 37.5 32.5 14.1 12.2 11.5 9.9 2.2 1.9 34.6 30.0 5.6 4.9 115.7 11.6 
Mean 38.8b 30.7b,c 14.9b 11.8b 12.2c 9.6a 2.3c 1.8a 39.9b 31.5b 5.7b 4.5a 126.4b,c 12.6b,c 
SEM 0.9 0.7 0.3 0.2 0.2 0.1 0.1 0.1 1.7 0.8 0.3 0.3 3.5 0.3 
Tinctures (n = 5) 
Oregon's Wild Harvest 28.4 29.2 10.6 10.9 8.7 9.0 1.7 1.8 32.0 32.9 4.5 4.6 97.3 9.7 
GAIA Herbs 22.8 35.2 9.3 14.3 5.5 8.4 0.6 1.0 20.1 31.0 1.2 1.9 64.8 6.5 
LA Naturals  5.1 40.2 1.7 13.4 1.1 8.6 0.2 1.4 3.0 23.1 0.7 5.6 12.8 1.3 
Teeter Creek 3.7 36.5 1.2 11.6 0.7 7.4 0.1 1.3 2.4 23.6 0.3 2.7 10.1 1.0 
Nature's Answer** 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.1 0.0 
Mean 15.0b 35.3c 5.7b 12.5b 4.0c 8.3a 0.7c 1.4a 14.3b 27.6b 1.7c 3.7a 46.3c 4.6c 
SEM 4.1 1.5 1.6 0.5 1.2 0.2 0.2 0.1 4.7 1.6 0.6 0.6 13.9 1.4 
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Table 4-4  Phytosterol quantities (mg/g) and composition (% of total phytosterols) in SRM, liquid and powder saw palmetto supplements. 
Supplement Campesterol Stigmasterol β-sitosterol Total phytosterols 
 mg/g % mg/g % mg/g % mg/g %* 
Liquids 
Jarrow Formulas** 8.33 29.09 4.01 14.03 16.29 56.88 28.63 2.86 
Doctor's Best 0.54 19.21 0.24 8.53 2.04 72.26 2.83 0.28 
Now Foods 0.29 12.56 0.13 5.66 1.92 81.78 2.35 0.23 
Saw Palmetto Harvesting Company 0.34 21.05 0.16 10.09 1.12 68.86 1.62 0.16 
Solaray 0.23 11.10 0.11 5.19 1.73 83.71 2.07 0.21 
Spring Valley Natural Foods 0.15 7.20 0.11 5.52 1.80 87.28 2.06 0.21 
GNC Herbal Plus 0.15 11.61 0.07 5.40 1.08 82.99 1.31 0.13 
Mean 0.28a 13.79a  0.14a  6.73a 1.62a 79.48a 2.04a 0.20a 
SEM 0.04 1.45 0.02 0.57   0.12 1.99   0.15 0.02  
Powders 
Biochem** 22.80 30.30 19.75 26.55 32.55 43.15 75.11 7.51 
Permixon 0.18 21.06 0.06 7.68 0.60 71.27 0.84 0.08 
Nature's Way 0.10 24.65 0.04 11.11 0.25 64.24 0.39 0.04 
Solaray 0.07 23.89 0.03 9.30 0.20 66.80 0.30 0.03 
GNC Saw Palmetto Formula 0.03 19.83 0.01 9.19 0.10 70.98 0.15 0.01 
Mean 0.09b 22.36b 0.04b,c 9.32a 0.29b 68.32b 0.42b 0.04b 
SEM 0.02 0.90 0.01 0.53 0.07 1.33 0.10 0.01 
Standard reference material 
SRM 3251 0.41 19.69 0.18 8.57 1.48 71.74 2.06 0.21 
*% dry mass (weight/weight), ** Jarrow Formulas and Biochem were excluded from statistical analysis due to their very high phytosterol  
content compared with other supplements. Different letters indicate significant differences (p<0.05) between the four categories. Samples,  
and SRM from the same lot, were extracted and analyzed in duplicate. 
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          Table 4-5 Phytosterol quantities (mg/g) and composition (% of total phytosterols) in dried berry and tincture saw palmetto supplements. 
Supplement Campesterol Stigmasterol β-sitosterol Total sterols 
 mg/g % mg/g % mg/g % mg/g %* 
Dried berries 
Mountain Rose Herbs (dried berries) 0.16 41.45 0.09 21.91 0.13 36.64 0.38 0.04 
Mountain Rose Herbs (powdered berries) 0.09 27.93 0.06 17.41 0.17 54.66 0.32 0.03 
More Than Alive (powdered berries) 0.08 27.28 0.07 22.06 0.15 50.66 0.30 0.03 
Mean 0.11b 32.22c 0.07b 20.46b 0.15b 47.32c 0.33b,c 0.03b 
SEM 0.02  3.30  0.01  2.86  0.01  5.16  0.03  0.00  
Tinctures 
Oregon's Wild Harvest 0.04 16.40 0.02 9.16 0.18 74.45 0.24 0.02 
GAIA Herbs 0.03 17.95 0.02 11.65 0.11 70.40 0.16 0.02 
LA Naturals Saw Palmetto drops 0.01 16.73 0.01 13.72 0.04 69.55 0.06 0.01 
Nature's Answer  0.00 21.12 0.00 25.23 0.01 53.65 0.02 0.00 
Teeter Creek 0.01 22.27 0.00 14.71 0.02 63.02 0.02 0.00 
Mean  0.02b 18.89a,b 0.01c  14.89b   0.07b 66.21b  0.10c 0.01b  
SEM 0.00  0.83 0.00  1.86   0.02 2.47  0.03  0.00  
* % of dry mass (weight/weight), different letters indicate significant differences (p<0.05) between the four categories.  
Samples, and SRM from the same lot, were extracted and analyzed in duplicate. 
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Table 4-6  Stated, measured, and percentage difference in total fatty acid content in liquid 
saw palmetto supplements. 
Product name Stated content 
(mg/g) 
Measured 
content 
(mg/g) 
% difference 
Doctor's Best 900 941 +5 
GNC Herbal Plus 850 934 +10 
Spring Valley Natural Foods 850-950 923 +3 
Now Foods 850-950 915 +2 
Solaray 850 913 +7 
Jarrow Formulas 850-950 833 -7 
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Chapter 5 - Summary & Future Directions 
 
The current research was carried out to screen different varieties of sorghum-based 
novel fortified blended foods and compare them with the traditional corn-soy FBFs. Products 
were assessed for bioavailable iron and vitamin A using the in-vitro digestion/Caco-2 cell 
model. In preliminary research (Chapter 2) with FBFs low in vitamins A, D and E; most 
extruded FBFs showed 2- to 4-fold significantly higher levels of iron in aqueous fractions 
than traditional FBFs. However similar differences were not observed in ferritin response. 
Extruded sorghum-cowpea, sorghum-soy and corn-soy showed iron bioavailability that was 
similar to non-extruded CSB13 and CSB+. 
   In the second part of our research (Chapter 3), all of the extruded FBFs had 4- to 7- 
fold significantly higher aqueous fraction iron concentrations compared to non-extruded 
CSB13 and CSB+. However, the Caco-2 cell ferritin response was similar between extruded 
and non-extruded FBFs. Also, vitamin A levels in aqueous fractions and Caco-2 cells were 
not different between extruded and non-extruded FBFs. 
The in vitro digestion-Caco-2 cell model needs further refinement to optimize the 
culture conditions and to standardize the technique to measure the bioavailability of multiple 
micronutrients. Inter-laboratory methodological differences such as growing cells on inserts 
compared to plastic surface, passage number, harvesting time and heat treatment of aqueous 
fraction may cause variation in the study outcomes. Even though both the studies (Chapter 2 
and Chapter 3) were conducted on similar FBFs, the methodology for Chapter-3 was 
modified to use cell lysis buffer as mechanical lysis did not work any longer. Ferritin 
response was also different between the two studies, and is approximately 3-times lower in 
Chapter-3. As this is the first study looking at both bioavailable iron and vitamin A levels, we 
used a method that did not grow cells on inserts, a common technique used in most iron 
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bioavailability studies. This modification allowed us to treat the Caco-2 cells directly with 
filtered aqueous fractions. Caution should be warranted for future studies using the in-vitro 
digestion/Caco-2 cell model as there were studies that did not find ferritin response above 
baseline levels [1, 2]. Future studies should also consider assessing the cell differentiation by 
measuring the brush border enzyme activity [3]. If the Caco-2 cells are not fully differentiated 
they express less number of transporters and cause lower nutrient uptake by cells. This 
information on cell differentiation time should be used in determining the day Caco-2 cells 
can be used for iron and vitamin A bioavailability experiment.  
The major difficulty in direct comparison of our results is that the extruded and 
traditional FBFs vary from each other in their composition, cooking, and iron fortificants 
used. Another difference was that the porridges were prepared at different solid 
concentrations. For example, extruded FBFs were cooked at 20% solids, whereas traditional 
FBFs were cooked at 12-14% solids. Also, unlike in other Caco-2 iron bioavailability studies 
[4, 5], iron concentration among the porridge aliquots used for in-vitro digestion were not 
same. However, the advantage of our porridges was that they were prepared similar to the 
porridges that are made at household level in food aid receiving countries such as Tanzania. 
This uniformity in porridge cooking methods would help in translation of current research 
findings to future human trials. 
Although, two sets of FBFs showed similar results with regards to bioavailable iron, 
this study could have been improved by including a non-extruded sorghum-cowpea or 
sorghum-soy FBF. This would have allowed us to determine the effect of extrusion on 
micronutrient bioavailability in sorghum FBFs. Even though extrusion is widely used in 
different food and feed applications [6], and has been shown to reduce antinutritional factors 
and improve iron bioavailability [7, 8], this processing technique was used for the first time 
on sorghum FBFs. As the study FBFs were newly developed, there were no other extruded 
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sorghum FBF studies available to compare our results. Hence, the study findings on extruded 
sorghum based FBFs may help in designing the food aid products, particularly in sorghum-
consuming regions like Africa and Asia. 
The amount of dietary fat and fiber were shown to have increasing and decreasing 
effect on vitamin A micellarization and absorption in animal [9, 10]. However, we did not 
observe differences in bioavailable vitamin A levels among FBFs with different fat levels. 
More Caco-2 cell model studies should determine the effect of fat and fiber on bioavailable 
vitamin A levels in FBFs. 
Another future direction is determining the antinutrient concentrations in extruded and 
non-extruded FBFs. In the present study, the increase in aqueous fraction iron concentrations 
might have partly contributed by phytate and tannin degradation to lower forms caused by 
extrusion. Quantification of total phytate, tannin and their degradation products in FBFs may 
help further understand the results.  
Finally, animal studies and field trials are needed to confirm the equal nutritional 
benefits of extruded sorghum based FBFs compared to traditional corn-soy FBFs. The broiler 
chicken model may be a suitable in-vivo model, as this model was shown to respond to iron 
deficiency and has advantages over rodent and pig models [11]. 
Liquid saw palmetto supplements contained significantly higher concentrations of total 
fatty acids, individual fatty acids, total phytosterols, and individual phytosterols than other saw 
palmetto categories such as powders, tinctures and dried berries. Studies suggest that the fatty 
acids in saw palmetto extracts are responsible for its ability to inhibit 5α-reductase [12, 13], 
an enzyme that converts testosterone to dihydrotestoterone leading to prostate hyperplasia, 
but which fatty acids are responsible for the inhibition varies. Hence future studies should 
determine the anti-androgen action of liquid saw palmetto supplements with different nutrient 
profiles in LNCap cells and prostate cancer animal models. 
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